CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | vitamin E |
|
Accession: | CHEBI:33234
|
browse the term
|
Definition: | Any member of a group of fat-soluble chromanols that exhibit biological activity against vitamin E deficiency. The vitamers in this class consists of a chroman-6-ol core which is substituted at position 2 by a methyl group and (also at position 2) either a saturated or a triply-unsaturated hydrocarbon chain consisting of three isoprenoid units. The major function of vitamin E is to act as a natural antioxidant by scavenging free radicals and molecular oxygen. |
Synonyms: | related_synonym: | vitamin E vitamer; vitamin E vitamers; vitamins E |
| alt_id: | MESH:D014810 |
| xref_mesh: | MESH:D024502 |
| xref: | MetaCyc:Vitamin-E; PMID:33684201; PMID:33847203; PMID:33896432; PMID:34277234; PMID:34278890; PMID:7898412; PMID:7901680; Wikipedia:Vitamin_E |
|
|
|
G |
Aamp |
angio-associated, migratory cell protein |
increases expression |
ISO |
Vitamin E results in increased expression of AAMP mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:75,863,382...75,869,188
Ensembl chr 9:75,863,389...75,868,547
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of AASS mRNA Vitamin E results in decreased expression of AASS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ABCB11 mRNA |
CTD |
PMID:34767876 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
EXP |
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of ABCC2 mRNA |
CTD |
PMID:11444866 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abhd14a |
abhydrolase domain containing 14A |
decreases expression |
ISO |
Vitamin E results in decreased expression of ABHD14A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:107,079,139...107,089,004
Ensembl chr 8:107,079,144...107,086,985
|
|
G |
Abhd2 |
abhydrolase domain containing 2, acylglycerol lipase |
decreases expression increases expression |
ISO |
Vitamin E results in decreased expression of ABHD2 mRNA Vitamin E results in increased expression of ABHD2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:133,217,403...133,298,564
Ensembl chr 1:133,217,375...133,299,061
|
|
G |
Abhd4 |
abhydrolase domain containing 4, N-acyl phospholipase B |
increases expression |
ISO |
Vitamin E results in increased expression of ABHD4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:27,697,384...27,716,013
Ensembl chr15:27,704,113...27,716,966
|
|
G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
increases expression |
ISO |
Vitamin E results in increased expression of ACAA2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
|
|
G |
Acads |
acyl-CoA dehydrogenase short chain |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ACADS mRNA Vitamin E results in increased expression of ACADS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:41,493,650...41,502,897
Ensembl chr12:41,493,626...41,502,898
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
ISO EXP |
[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of ACHE protein; Hexachlorocyclohexane inhibits the reaction [[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of ACHE protein] [Zinc co-treated with Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [sodium arsenite results in increased activity of ACHE protein]; Vitamin E inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased activity of ACHE protein]; Vitamin E inhibits the reaction [Scopolamine results in decreased activity of ACHE protein] |
CTD |
PMID:11814146 PMID:20663516 PMID:23619517 PMID:29233033 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Aco2 |
aconitase 2 |
increases expression |
ISO |
Vitamin E results in increased expression of ACO2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:113,385,677...113,428,794
Ensembl chr 7:113,385,646...113,428,261
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ACOT2 mRNA Vitamin E results in increased expression of ACOT2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245
|
|
G |
Acp1 |
acid phosphatase 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ACP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:47,506,380...47,522,021
Ensembl chr 6:47,506,380...47,522,021
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
decreases expression |
ISO |
Vitamin E results in decreased expression of ACTA2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Actb |
actin, beta |
increases expression |
ISO |
Vitamin E results in increased expression of ACTB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Actn4 |
actinin alpha 4 |
increases expression |
ISO |
Vitamin E results in increased expression of ACTN4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:84,182,783...84,251,867
Ensembl chr 1:84,182,788...84,251,847
|
|
G |
Actr1a |
actin related protein 1A |
increases expression |
ISO |
Vitamin E results in increased expression of ACTR1A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:245,237,821...245,256,618
Ensembl chr 1:245,237,826...245,256,495
|
|
G |
Actr1b |
actin related protein 1B |
increases expression |
ISO |
Vitamin E results in increased expression of ACTR1B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:38,928,819...38,938,483
Ensembl chr 9:38,929,912...38,938,507
|
|
G |
Acvr2a |
activin A receptor type 2A |
decreases expression |
ISO |
Vitamin E results in decreased expression of ACVR2A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:33,204,961...33,292,673
Ensembl chr 3:33,205,523...33,289,968
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ADAM17 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
|
|
G |
Adamts5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ADAMTS5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:25,000,627...25,047,205
Ensembl chr11:25,000,637...25,047,205
|
|
G |
Adap1 |
ArfGAP with dual PH domains 1 |
increases expression |
ISO |
Vitamin E results in increased expression of ADAP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:15,323,913...15,376,110
Ensembl chr12:15,324,209...15,380,831
|
|
G |
Adarb1 |
adenosine deaminase, RNA-specific, B1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ADARB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:11,222,569...11,350,854
Ensembl chr20:11,222,583...11,350,852
|
|
G |
Adcy2 |
adenylate cyclase 2 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ADCY2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:34,375,639...34,822,252
Ensembl chr 1:34,375,895...34,822,236
|
|
G |
Adcy6 |
adenylate cyclase 6 |
increases expression |
ISO |
Vitamin E results in increased expression of ADCY6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:129,742,827...129,763,922
Ensembl chr 7:129,742,838...129,763,754
|
|
G |
Add1 |
adducin 1 |
increases expression |
ISO |
Vitamin E results in increased expression of ADD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:76,108,643...76,167,267
Ensembl chr14:76,108,654...76,167,182
|
|
G |
Add3 |
adducin 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ADD3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:252,147,341...252,255,126
Ensembl chr 1:252,147,386...252,255,124
|
|
G |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
increases expression |
ISO |
Vitamin E results in increased expression of ADGRB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:106,404,827...106,476,902
Ensembl chr 7:106,404,958...106,476,902
|
|
G |
Adh7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
decreases expression |
ISO |
Vitamin E results in decreased expression of ADH7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:226,748,724...226,763,183
Ensembl chr 2:226,741,788...226,763,182
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ mRNA]; Vitamin E inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein] |
CTD |
PMID:20404018 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adissp |
adipose secreted signaling protein |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of ADISSP mRNA [Selenium co-treated with Vitamin E] results in decreased expression of ADISSP mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:118,364,730...118,378,881
Ensembl chr 3:118,362,363...118,378,838
|
|
G |
Adra2c |
adrenoceptor alpha 2C |
increases expression |
ISO |
Vitamin E results in increased expression of ADRA2C mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:75,470,884...75,472,846
Ensembl chr14:75,471,143...75,472,846
|
|
G |
Adrm1 |
ADRM1 26S proteasome ubiquitin receptor |
increases expression |
ISO |
Vitamin E results in increased expression of ADRM1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:167,265,435...167,270,197
Ensembl chr 3:167,265,296...167,270,195
|
|
G |
Aebp1 |
AE binding protein 1 |
increases expression |
ISO |
Vitamin E results in increased expression of AEBP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:80,738,800...80,748,878
Ensembl chr14:80,738,892...80,748,877
|
|
G |
Aen |
apoptosis enhancing nuclease |
increases expression |
ISO |
Vitamin E results in increased expression of AEN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:132,815,094...132,824,522
Ensembl chr 1:132,815,142...132,824,523
|
|
G |
Agpat2 |
1-acylglycerol-3-phosphate O-acyltransferase 2 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of AGPAT2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:9,416,837...9,428,567
Ensembl chr 3:9,416,843...9,428,371
|
|
G |
Agrn |
agrin |
decreases expression |
ISO |
Vitamin E results in decreased expression of AGRN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:166,749,306...166,782,212
Ensembl chr 5:166,749,310...166,786,003
|
|
G |
Agtpbp1 |
ATP/GTP binding carboxypeptidase 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of AGTPBP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:5,120,540...5,238,874
Ensembl chr17:5,120,609...5,238,869
|
|
G |
Ahnak |
AHNAK nucleoprotein |
increases expression |
ISO |
Vitamin E results in increased expression of AHNAK mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:205,882,225...205,970,934
Ensembl chr 1:205,882,273...205,970,926
|
|
G |
Ahnak2 |
AHNAK nucleoprotein 2 |
increases expression |
ISO |
Vitamin E results in increased expression of AHNAK2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:131,830,668...131,876,311
Ensembl chr 6:131,831,454...131,854,463
|
|
G |
Ahr |
aryl hydrocarbon receptor |
decreases expression |
ISO |
Vitamin E results in decreased expression of AHR mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Ahsa1 |
activator of Hsp90 ATPase activity 1 |
increases expression |
ISO |
Vitamin E results in increased expression of AHSA1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:106,913,296...106,921,347
Ensembl chr 6:106,913,530...106,921,345
|
|
G |
Aimp1 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of AIMP1 mRNA Vitamin E results in decreased expression of AIMP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:221,151,907...221,175,458
Ensembl chr 2:221,151,904...221,175,728
|
|
G |
Ak1 |
adenylate kinase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of AK1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:15,912,431...15,923,045
Ensembl chr 3:15,912,485...15,923,041
|
|
G |
Ak3 |
adenylate kinase 3 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of AK3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625
|
|
G |
Akap13 |
A-kinase anchoring protein 13 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of AKAP13 mRNA Vitamin E results in decreased expression of AKAP13 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:129,313,183...129,619,647
Ensembl chr 1:129,314,402...129,619,646
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
increases expression |
ISO |
Vitamin E results in increased expression of AKR1B1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases expression |
ISO |
Vitamin E results in increased expression of AKR1B10 mRNA |
CTD |
PMID:34767876 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
Vitamin E results in increased expression of AKR1C2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases expression multiple interactions |
ISO EXP |
Vitamin E results in increased expression of AKT1 mRNA [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:19244175 PMID:21911000 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alad |
aminolevulinate dehydratase |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [lead acetate results in decreased activity of ALAD protein] |
CTD |
PMID:2604901 |
|
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
|
|
G |
Alb |
albumin |
multiple interactions |
ISO EXP |
Vitamin E inhibits the reaction [Ethanol results in decreased expression of ALB protein] [Quercetin co-treated with Vitamin E] inhibits the reaction [Cyclosporine results in decreased expression of ALB protein]; Vitamin E inhibits the reaction [Cyclosporine results in decreased expression of ALB protein] Vitamin E inhibits the reaction [Oleic Acid results in decreased secretion of ALB protein] |
CTD |
PMID:17927767 PMID:21086752 PMID:23348005 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ALDH6A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
|
|
G |
Aldoa |
aldolase, fructose-bisphosphate A |
increases expression |
ISO |
Vitamin E results in increased expression of ALDOA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
|
|
G |
Alg3 |
ALG3, alpha-1,3- mannosyltransferase |
increases expression |
ISO |
Vitamin E results in increased expression of ALG3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:80,300,487...80,306,014
Ensembl chr11:80,300,498...80,307,912
|
|
G |
Alg9 |
ALG9, alpha-1,2-mannosyltransferase |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ALG9 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:51,117,057...51,188,790
Ensembl chr 8:51,119,365...51,182,261
|
|
G |
Alkbh1 |
alkB homolog 1, histone H2A dioxygenase |
decreases expression |
ISO |
Vitamin E results in decreased expression of ALKBH1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:107,068,301...107,088,784
Ensembl chr 6:107,068,475...107,088,759
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
decreases activity multiple interactions |
ISO EXP |
Vitamin E results in decreased activity of ALOX5 protein [Vitamin E co-treated with Selenium] results in decreased expression of ALOX5 mRNA; [Vitamin E co-treated with Selenium] results in decreased expression of ALOX5 protein |
CTD |
PMID:11325678 PMID:12200813 PMID:22223226 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Doxorubicin results in decreased activity of ALPL protein]; Vitamin E inhibits the reaction [Hexachlorobenzene results in increased activity of ALPL protein]; Vitamin E inhibits the reaction [Tramadol results in increased expression of ALPL protein] |
CTD |
PMID:30064338 PMID:31618080 PMID:32810592 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Ambra1 |
autophagy and beclin 1 regulator 1 |
increases expression |
ISO |
Vitamin E results in increased expression of AMBRA1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:77,700,936...77,890,221
Ensembl chr 3:77,700,936...77,890,221
|
|
G |
Anapc15 |
anaphase promoting complex subunit 15 |
increases expression |
ISO |
Vitamin E results in increased expression of ANAPC15 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:156,238,640...156,266,005
Ensembl chr 1:156,262,841...156,268,145
|
|
G |
Andpro |
androgen regulated protein |
decreases expression |
EXP |
Vitamin E results in decreased expression of ANDPRO mRNA |
CTD |
PMID:15084515 |
|
NCBI chr 3:136,718,601...136,725,131
Ensembl chr 3:136,718,602...136,724,966
|
|
G |
Angpt1 |
angiopoietin 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ANGPT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
|
|
G |
Ank3 |
ankyrin 3 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ANK3 mRNA Vitamin E results in decreased expression of ANK3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:18,602,267...19,225,831
Ensembl chr20:18,602,786...19,086,300
|
|
G |
Ankrd12 |
ankyrin repeat domain 12 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ANKRD12 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:105,583,273...105,687,957
Ensembl chr 9:105,584,065...105,687,911
|
|
G |
Anp32b |
acidic nuclear phosphoprotein 32 family member B |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ANP32B mRNA Vitamin E results in decreased expression of ANP32B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:60,743,077...60,765,726
Ensembl chr 5:60,743,443...60,765,717
|
|
G |
Anxa6 |
annexin A6 |
increases expression |
ISO |
Vitamin E results in increased expression of ANXA6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433
|
|
G |
Ap1m2 |
adaptor related protein complex 1 subunit mu 2 |
increases expression |
ISO |
Vitamin E results in increased expression of AP1M2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:19,838,579...19,856,560
Ensembl chr 8:19,838,580...19,856,482
|
|
G |
Ap2a2 |
adaptor related protein complex 2 subunit alpha 2 |
increases expression |
ISO |
Vitamin E results in increased expression of AP2A2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:196,652,315...196,725,609
Ensembl chr 1:196,652,337...196,725,603
|
|
G |
Ap2m1 |
adaptor related protein complex 2 subunit mu 1 |
increases expression |
ISO |
Vitamin E results in increased expression of AP2M1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:80,355,307...80,364,218
Ensembl chr11:80,328,041...80,364,140
|
|
G |
Ap2s1 |
adaptor related protein complex 2 subunit sigma 1 |
increases expression |
ISO |
Vitamin E results in increased expression of AP2S1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:77,417,496...77,428,903
Ensembl chr 1:77,417,477...77,428,905
|
|
G |
Ap3s2 |
adaptor related protein complex 3 subunit sigma 2 |
increases expression |
ISO |
Vitamin E results in increased expression of AP3S2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:133,818,825...133,859,269
Ensembl chr 1:133,818,825...133,859,322
|
|
G |
Apbb2 |
amyloid beta precursor protein binding family B member 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of APBB2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:41,557,918...41,878,622
Ensembl chr14:41,557,972...41,877,495
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
increases expression |
ISO |
Vitamin E results in increased expression of APEX1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Aplp2 |
amyloid beta precursor like protein 2 |
increases expression |
ISO |
Vitamin E results in increased expression of APLP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:29,599,230...29,662,311
Ensembl chr 8:29,599,230...29,661,855
|
|
G |
Apoa1 |
apolipoprotein A1 |
increases expression |
ISO |
Vitamin E results in increased expression of APOA1 protein |
CTD |
PMID:18458655 |
|
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Apob |
apolipoprotein B |
multiple interactions |
ISO |
[Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Oleic Acid co-treated with Folic Acid co-treated with Vitamin B 6 co-treated with Vitamin E] results in decreased expression of APOB protein; Vitamin E promotes the reaction [Flavonoids inhibits the reaction [Copper results in increased oxidation of APOB protein]]; Vitamin E promotes the reaction [Quercetin inhibits the reaction [Copper results in increased oxidation of APOB protein]] |
CTD |
PMID:17237316 PMID:17475462 |
|
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
|
|
G |
Apoe |
apolipoprotein E |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [APOE mutant form results in increased abundance of 8,12-iso-isoprostane F2alpha-VI] |
CTD |
PMID:16303615 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Apom |
apolipoprotein M |
increases expression |
ISO |
Vitamin E results in increased expression of APOM mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:3,690,950...3,693,550
Ensembl chr20:3,688,413...3,693,550
|
|
G |
App |
amyloid beta precursor protein |
decreases expression multiple interactions |
ISO EXP |
Vitamin E results in decreased expression of APP mRNA Vitamin E inhibits the reaction [APP protein modified form promotes the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 protein]]; Vitamin E inhibits the reaction [APP protein results in increased activity of CASP3] Vitamin E inhibits the reaction [Aluminum results in increased cleavage of APP protein] |
CTD |
PMID:12039845 PMID:12117551 PMID:15223066 PMID:19244175 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Appbp2 |
amyloid beta precursor protein binding protein 2 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of APPBP2 mRNA Vitamin E results in increased expression of APPBP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:70,057,774...70,099,877
Ensembl chr10:70,057,774...70,099,835
|
|
G |
Aqp1 |
aquaporin 1 |
increases expression |
ISO |
Vitamin E results in increased expression of AQP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of AQP3 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of AQP3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
|
|
G |
Aqp4 |
aquaporin 4 |
multiple interactions |
EXP ISO |
Vitamin E inhibits the reaction [manganese(III) acetate dihydrate results in increased expression of AQP4 protein] Vitamin E inhibits the reaction [[ferrous chloride results in increased abundance of Iron] which results in increased expression of AQP4 protein] |
CTD |
PMID:20648640 PMID:30914277 |
|
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
|
|
G |
Araf |
A-Raf proto-oncogene, serine/threonine kinase |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ARAF mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:1,227,392...1,292,356
Ensembl chr X:1,227,392...1,239,073
|
|
G |
Arf3 |
ARF GTPase 3 |
increases expression |
ISO |
Vitamin E results in increased expression of ARF3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:129,886,082...129,912,022
Ensembl chr 7:129,886,082...129,912,002
|
|
G |
Arf5 |
ARF GTPase 5 |
increases expression |
ISO |
Vitamin E results in increased expression of ARF5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:57,038,521...57,041,447
Ensembl chr 4:57,038,521...57,041,441
|
|
G |
Arhgap10 |
Rho GTPase activating protein 10 |
increases expression |
ISO |
Vitamin E results in increased expression of ARHGAP10 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:30,448,572...30,710,315
Ensembl chr19:30,448,637...30,710,313
|
|
G |
Arhgap8 |
Rho GTPase activating protein 8 |
increases expression |
ISO |
Vitamin E results in increased expression of ARHGAP8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:115,842,223...115,902,094
Ensembl chr 7:115,850,654...115,902,093
|
|
G |
Arhgdia |
Rho GDP dissociation inhibitor alpha |
increases expression |
ISO |
Vitamin E results in increased expression of ARHGDIA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:105,854,526...105,858,020
Ensembl chr10:105,854,533...105,858,023
|
|
G |
Arih1 |
ariadne RBR E3 ubiquitin protein ligase 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ARIH1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:59,777,378...59,879,762
Ensembl chr 8:59,777,379...59,880,245
|
|
G |
Arl4d |
ARF like GTPase 4D |
increases expression |
ISO |
Vitamin E results in increased expression of ARL4D mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:86,592,054...86,602,843
Ensembl chr10:86,595,661...86,602,836
|
|
G |
Arl6ip4 |
ARF like GTPase 6 interacting protein 4 |
increases expression |
ISO |
Vitamin E results in increased expression of ARL6IP4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:32,479,623...32,481,768
Ensembl chr12:32,479,625...32,481,799
|
|
G |
Arpc1a |
actin related protein 2/3 complex, subunit 1A |
increases expression |
ISO |
Vitamin E results in increased expression of ARPC1A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:9,502,496...9,525,304
Ensembl chr12:9,502,501...9,525,330
|
|
G |
Arpc4 |
actin related protein 2/3 complex, subunit 4 |
increases expression |
ISO |
Vitamin E results in increased expression of ARPC4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:146,522,255...146,532,784
Ensembl chr 4:146,522,176...146,532,785
|
|
G |
Asap3 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 |
increases expression |
ISO |
Vitamin E results in increased expression of ASAP3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:148,433,382...148,476,027
Ensembl chr 5:148,433,494...148,474,073
|
|
G |
Asb1 |
ankyrin repeat and SOCS box-containing 1 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ASB1 mRNA Vitamin E results in increased expression of ASB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:92,120,332...92,140,790
Ensembl chr 9:92,120,306...92,136,376
|
|
G |
Asxl1 |
ASXL transcriptional regulator 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ASXL1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:141,814,012...141,881,526
Ensembl chr 3:141,813,433...141,881,538
|
|
G |
Atf2 |
activating transcription factor 2 |
increases phosphorylation |
ISO |
Vitamin E results in increased phosphorylation of ATF2 protein |
CTD |
PMID:11522656 |
|
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
|
|
G |
Atf3 |
activating transcription factor 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATF3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf5 |
activating transcription factor 5 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ATF5 mRNA Vitamin E results in increased expression of ATF5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
|
|
G |
Atg12 |
autophagy related 12 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATG12 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:39,452,247...39,462,424
Ensembl chr18:39,452,191...39,462,418
|
|
G |
Atmin |
ATM interactor |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ATMIN mRNA Vitamin E results in decreased expression of ATMIN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:44,996,506...45,013,606
Ensembl chr19:44,996,356...45,013,605
|
|
G |
Atox1 |
antioxidant 1 copper chaperone |
increases expression |
ISO |
Vitamin E results in increased expression of ATOX1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:39,564,855...39,579,892
Ensembl chr10:39,564,857...39,579,950
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
increases expression |
ISO |
Vitamin E results in increased expression of ATP5F1B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:515,454...521,858
Ensembl chr 7:515,460...567,273
|
|
G |
Atp5f1c |
ATP synthase F1 subunit gamma |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATP5F1C mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:68,423,927...68,446,169
Ensembl chr17:68,423,909...68,608,367
|
|
G |
Atp5me |
ATP synthase membrane subunit e |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATP5ME mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:1,319,868...1,320,996
Ensembl chr14:1,319,868...1,321,013
|
|
G |
Atp6ap2 |
ATPase H+ transporting accessory protein 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATP6AP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:10,183,983...10,210,948
Ensembl chr X:10,183,068...10,210,918
|
|
G |
Atp6v0d1 |
ATPase H+ transporting V0 subunit D1 |
increases expression |
ISO |
Vitamin E results in increased expression of ATP6V0D1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:33,403,352...33,447,357
Ensembl chr19:33,403,355...33,447,450
|
|
G |
Atp6v1c1 |
ATPase H+ transporting V1 subunit C1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATP6V1C1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:69,834,464...69,872,278
Ensembl chr 7:69,834,463...69,872,278
|
|
G |
Atp8b1 |
ATPase phospholipid transporting 8B1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATP8B1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:58,016,382...58,157,213
Ensembl chr18:58,018,268...58,157,396
|
|
G |
Atrx |
ATRX, chromatin remodeler |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of ATRX mRNA [Selenium co-treated with Vitamin E] results in decreased expression of ATRX mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:70,850,981...70,997,330
Ensembl chr X:70,850,981...70,997,330
|
|
G |
Atxn3 |
ataxin 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATXN3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:121,072,228...121,107,902
Ensembl chr 6:121,074,448...121,107,902
|
|
G |
Atxn7 |
ataxin 7 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ATXN7 mRNA Vitamin E results in decreased expression of ATXN7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:11,117,360...11,262,818
Ensembl chr15:11,118,886...11,263,106
|
|
G |
Auts2 |
activator of transcription and developmental regulator AUTS2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of AUTS2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:24,104,187...25,194,123
Ensembl chr12:24,104,192...25,194,416
|
|
G |
Axl |
Axl receptor tyrosine kinase |
decreases expression |
ISO |
Vitamin E results in decreased expression of AXL mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:81,265,088...81,296,278
Ensembl chr 1:81,265,088...81,296,265
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
increases expression |
EXP |
Vitamin E results in increased expression of BAAT mRNA |
CTD |
PMID:28923436 |
|
NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685
|
|
G |
Babam1 |
BRISC and BRCA1 A complex member 1 |
increases expression |
ISO |
Vitamin E results in increased expression of BABAM1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:18,068,830...18,074,938
Ensembl chr16:18,068,884...18,074,923
|
|
G |
Babam2 |
BRISC and BRCA1 A complex member 2 |
increases expression |
ISO |
Vitamin E results in increased expression of BABAM2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:24,369,021...24,788,416
Ensembl chr 6:24,369,022...24,833,951
|
|
G |
Bag5 |
BAG cochaperone 5 |
decreases expression |
ISO |
Vitamin E results in decreased expression of BAG5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:130,768,467...130,772,122
Ensembl chr 6:130,768,141...130,772,970
|
|
G |
Bag6 |
BAG cochaperone 6 |
increases expression |
ISO |
Vitamin E results in increased expression of BAG6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:3,675,938...3,690,414
Ensembl chr20:3,675,938...3,688,657
|
|
G |
Banf1 |
barrier to autointegration nuclear assembly factor 1 |
increases expression |
ISO |
Vitamin E results in increased expression of BANF1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:202,672,170...202,674,215
Ensembl chr 1:202,671,305...202,674,188
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of BAP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:6,446,709...6,455,535
Ensembl chr16:6,446,709...6,455,535
|
|
G |
Bard1 |
BRCA1 associated RING domain 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of BARD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265
|
|
G |
Batf |
basic leucine zipper ATF-like transcription factor |
increases expression |
ISO |
Vitamin E results in increased expression of BATF mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:105,353,715...105,376,051
Ensembl chr 6:105,353,715...105,376,051
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions affects expression increases expression |
ISO EXP |
Vitamin E inhibits the reaction [bioallethrin results in increased expression of BAX protein]; Vitamin E inhibits the reaction [cinnamaldehyde results in increased expression of BAX protein]; Vitamin E inhibits the reaction [Curcumin results in decreased expression of BAX protein]; Vitamin E inhibits the reaction [phenethyl isothiocyanate results in increased expression of BAX protein] [Vitamin E co-treated with Folic Acid] affects the expression of BAX protein; Vitamin E inhibits the reaction [Diazinon results in increased expression of BAX mRNA]; Vitamin E inhibits the reaction [Diazinon results in increased expression of BAX protein]; Vitamin E inhibits the reaction [Nanotubes, Carbon results in increased expression of BAX protein] Vitamin E affects the expression of BAX protein Vitamin E results in increased expression of BAX protein |
CTD |
PMID:11166918 PMID:15566391 PMID:16054126 PMID:16933212 PMID:22020378 PMID:23523949 PMID:27353299 PMID:30935902 PMID:35511042 More...
|
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Baz1a |
bromodomain adjacent to zinc finger domain, 1A |
decreases expression |
ISO |
Vitamin E results in decreased expression of BAZ1A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:72,389,701...72,512,516
Ensembl chr 6:72,389,703...72,512,459
|
|
G |
Baz1b |
bromodomain adjacent to zinc finger domain, 1B |
increases expression |
ISO |
Vitamin E results in increased expression of BAZ1B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:21,431,985...21,489,956
Ensembl chr12:21,431,985...21,490,426
|
|
G |
Bbx |
BBX high mobility group box domain containing |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of BBX mRNA Vitamin E results in decreased expression of BBX mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:50,381,249...50,628,934
Ensembl chr11:50,381,247...50,623,251
|
|
G |
Bcap31 |
B-cell receptor-associated protein 31 |
increases expression |
ISO |
Vitamin E results in increased expression of BCAP31 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:151,397,567...151,429,666
Ensembl chr X:151,397,576...151,428,506
|
|
G |
Bche |
butyrylcholinesterase |
multiple interactions |
ISO |
[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of BCHE protein; Hexachlorocyclohexane inhibits the reaction [[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of BCHE protein] |
CTD |
PMID:20663516 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bcl11a |
BCL11 transcription factor A |
decreases expression |
ISO |
Vitamin E results in decreased expression of BCL11A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:98,029,018...98,124,181
Ensembl chr14:98,030,461...98,124,180
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions increases expression |
ISO EXP |
[Vitamin E co-treated with Curcumin] results in decreased expression of BCL2 protein; Vitamin E inhibits the reaction [cinnamaldehyde results in decreased expression of BCL2 protein] Vitamin E results in increased expression of BCL2 mRNA [Vitamin E co-treated with Folic Acid] affects the expression of BCL2 protein; Vitamin E inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA]; Vitamin E inhibits the reaction [Nanotubes, Carbon results in decreased expression of BCL2 protein] |
CTD |
PMID:15566391 PMID:16933212 PMID:22020378 PMID:27353299 PMID:30935902 PMID:32810592 More...
|
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions increases expression |
EXP ISO |
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BCL2L1 mRNA Vitamin E results in increased expression of BCL2L1 mRNA |
CTD |
PMID:11444866 PMID:19244175 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bcl6 |
BCL6, transcription repressor |
decreases expression |
ISO |
Vitamin E results in decreased expression of BCL6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
|
|
G |
Bclaf1 |
BCL2-associated transcription factor 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of BCLAF1 mRNA Vitamin E results in decreased expression of BCLAF1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:15,088,436...15,117,666
Ensembl chr 1:15,070,894...15,148,832
|
|
G |
Bco1 |
beta-carotene oxygenase 1 |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Oxidants inhibits the reaction [BCO1 protein results in increased oxidation of beta Carotene]] |
CTD |
PMID:9526112 |
|
NCBI chr19:45,149,250...45,186,102
Ensembl chr19:45,149,265...45,186,101
|
|
G |
Becn1 |
beclin 1 |
multiple interactions decreases expression |
EXP |
Vitamin E inhibits the reaction [Pilocarpine results in increased expression of BECN1 mRNA]; Vitamin E inhibits the reaction [Pilocarpine results in increased expression of BECN1 protein] Vitamin E results in decreased expression of BECN1 protein |
CTD |
PMID:19138675 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Doxorubicin results in increased expression of BGLAP protein] |
CTD |
PMID:32810592 |
|
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
|
|
G |
Bicd1 |
BICD cargo adaptor 1 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of BICD1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of BICD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:182,479,071...182,631,504
Ensembl chr 4:182,479,071...182,627,434
|
|
G |
Bicd2 |
BICD cargo adaptor 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of BICD2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:15,259,773...15,304,889
Ensembl chr17:15,259,773...15,304,889
|
|
G |
Bin1 |
bridging integrator 1 |
increases expression |
ISO |
Vitamin E results in increased expression of BIN1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:24,009,731...24,067,267
Ensembl chr18:24,009,653...24,067,263
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
multiple interactions |
EXP ISO |
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BIRC2 mRNA Vitamin E inhibits the reaction [cinnamaldehyde results in decreased expression of BIRC2 protein] |
CTD |
PMID:11444866 PMID:15566391 |
|
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [cinnamaldehyde results in decreased expression of BIRC3 protein] |
CTD |
PMID:15566391 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [Benzo(a)pyrene results in decreased expression of BIRC5 protein] |
CTD |
PMID:24664296 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bles03 |
basophilic leukemia expressed protein BLES03 |
increases expression |
ISO |
Vitamin E results in increased expression of C11ORF68 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:202,734,555...202,736,809
Ensembl chr 1:202,734,555...202,736,804
|
|
G |
Bltp2 |
bridge-like lipid transfer protein family member 2 |
increases expression |
ISO |
Vitamin E results in increased expression of BLTP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:63,155,999...63,185,213
Ensembl chr10:63,156,044...63,191,141
|
|
G |
Bltp3b |
bridge-like lipid transfer protein family member 3B |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of BLTP3B mRNA Vitamin E results in decreased expression of BLTP3B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:24,181,635...24,261,720
Ensembl chr 7:24,181,644...24,261,720
|
|
G |
Blvra |
biliverdin reductase A |
increases expression |
ISO |
Vitamin E results in increased expression of BLVRA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:114,340,778...114,366,048
Ensembl chr 3:114,340,838...114,366,033
|
|
G |
Bmp2k |
BMP-2 inducible kinase |
decreases expression |
ISO |
Vitamin E results in decreased expression of BMP2K mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:12,481,194...12,579,411
Ensembl chr14:12,484,729...12,579,134
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
increases expression |
ISO |
Vitamin E results in increased expression of BMP4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
|
|
G |
Bptf |
bromodomain PHD finger transcription factor |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of BPTF mRNA Vitamin E results in decreased expression of BPTF mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:91,980,279...92,082,731
Ensembl chr10:91,982,758...92,082,769
|
|
G |
Brd2 |
bromodomain containing 2 |
multiple interactions decreases expression increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of BRD2 mRNA Vitamin E results in decreased expression of BRD2 mRNA Vitamin E results in increased expression of BRD2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:4,727,078...4,735,389
Ensembl chr20:4,728,151...4,735,388
|
|
G |
Brf2 |
BRF2 general transcription factor 3B subunit |
increases expression |
ISO |
Vitamin E results in increased expression of BRF2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:64,928,334...64,933,057
Ensembl chr16:64,928,300...64,933,059
|
|
G |
Brms1 |
BRMS1, transcriptional repressor and anoikis regulator |
increases expression |
ISO |
Vitamin E results in increased expression of BRMS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:202,345,766...202,355,028
Ensembl chr 1:202,345,704...202,355,028
|
|
G |
Bscl2 |
BSCL2 lipid droplet biogenesis associated, seipin |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of BSCL2 mRNA Vitamin E results in increased expression of BSCL2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:205,731,828...205,743,430
Ensembl chr 1:205,733,872...205,743,421
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
increases expression |
ISO |
Vitamin E results in increased expression of BST2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
|
|
G |
C1s |
complement C1s |
increases expression |
ISO |
Vitamin E results in increased expression of C1S mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303
|
|
G |
C4h2orf42 |
similar to human chromosome 2 open reading frame 42 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of C2ORF42 mRNA Vitamin E results in decreased expression of C2ORF42 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:118,887,688...118,916,808
Ensembl chr 4:118,888,112...118,916,936
|
|
G |
C5h1orf216 |
similar to human chromosome 1 open reading frame 216 |
increases expression |
ISO |
Vitamin E results in increased expression of C1ORF216 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:138,900,045...138,905,267
Ensembl chr 5:138,900,581...138,905,273
|
|
G |
C5h1orf50 |
similar to human chromosome 1 open reading frame 50 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of C1ORF50 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of C1ORF50 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:132,837,135...132,841,744
Ensembl chr 5:132,836,506...132,841,762
|
|
G |
C7h8orf33 |
similar to human chromosome 8 open reading frame 33 |
increases expression |
ISO |
Vitamin E results in increased expression of C8ORF33 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:108,682,122...108,684,372
Ensembl chr 7:108,682,176...108,684,358
|
|
G |
Caap1 |
caspase activity and apoptosis inhibitor 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CAAP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:109,313,253...109,414,323
Ensembl chr 5:109,361,912...109,414,314
|
|
G |
Cab39 |
calcium binding protein 39 |
increases expression |
ISO |
Vitamin E results in increased expression of MO25 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:86,463,095...86,524,545
Ensembl chr 9:86,463,095...86,524,544
|
|
G |
Cald1 |
caldesmon 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CALD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:63,265,781...63,446,938
Ensembl chr 4:63,265,942...63,446,932
|
|
G |
Calm3 |
calmodulin 3 |
increases expression |
ISO |
Vitamin E results in increased expression of CALM3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:77,590,668...77,597,776
Ensembl chr 1:77,589,230...77,592,207
|
|
G |
Calr |
calreticulin |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CALR mRNA Vitamin E results in decreased expression of CALR mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Calu |
calumenin |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CALU mRNA Vitamin E results in increased expression of CALU mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
increases expression |
ISO |
Vitamin E results in increased expression of CAMK2B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
|
|
G |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
decreases expression |
ISO |
Vitamin E results in decreased expression of CAMK2G mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:3,504,017...3,563,050
Ensembl chr15:3,504,085...3,563,050
|
|
G |
Cap1 |
cyclase associated actin cytoskeleton regulatory protein 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CAP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:135,142,108...135,168,885
Ensembl chr 5:135,142,112...135,168,769
|
|
G |
Capg |
capping actin protein, gelsolin like |
increases expression |
ISO |
Vitamin E results in increased expression of CAPG mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
|
|
G |
Capn7 |
calpain 7 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CAPN7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:6,545,630...6,581,908
Ensembl chr16:6,545,731...6,581,905
|
|
G |
Capns1 |
calpain, small subunit 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CAPNS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:85,444,613...85,454,861
Ensembl chr 1:85,444,608...85,454,795
|
|
G |
Caprin2 |
caprin family member 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CAPRIN2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:181,806,105...181,860,754
Ensembl chr 4:181,806,575...181,860,830
|
|
G |
Capzb |
capping actin protein of muscle Z-line subunit beta |
increases expression |
ISO |
Vitamin E results in increased expression of CAPZB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:151,435,600...151,535,409
Ensembl chr 5:151,434,871...151,535,409
|
|
G |
Car3 |
carbonic anhydrase 3 |
multiple interactions |
EXP |
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of CA3 mRNA |
CTD |
PMID:11444866 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Casc3 |
CASC3 exon junction complex subunit |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of MLN51 mRNA Vitamin E results in increased expression of MLN51 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:83,769,014...83,788,966
Ensembl chr10:83,769,001...83,788,966
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression |
ISO EXP |
Vitamin E inhibits the reaction [bioallethrin results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [cinnamaldehyde results in increased activity of CASP3 protein]; Vitamin E inhibits the reaction [Curcumin results in decreased expression of CASP3 protein]; Vitamin E inhibits the reaction [osimertinib results in increased expression of CASP3 protein modified form]; Vitamin E inhibits the reaction [phenethyl isothiocyanate results in increased activity of CASP3 protein] Vitamin E results in increased expression of CASP3 mRNA Vitamin E inhibits the reaction [titanium dioxide results in increased activity of CASP3 protein] [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dichlorvos results in increased activity of CASP3 protein]; [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP3 mRNA]; Vitamin E inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [Acrylamide results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [APP protein results in increased activity of CASP3]; Vitamin E inhibits the reaction [Diazinon results in increased activity of CASP3 protein]; Vitamin E inhibits the reaction [Diazinon results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [Diazinon results in increased expression of CASP3 protein modified form]; Vitamin E inhibits the reaction [Doxorubicin results in decreased expression of CASP3 mRNA]; Vitamin E inhibits the reaction [Nanotubes, Carbon results in increased activity of CASP3 protein]; Vitamin E inhibits the reaction [Tramadol results in increased expression of CASP3 protein] |
CTD |
PMID:12117551 PMID:15566391 PMID:16054126 PMID:16973328 PMID:21628957 PMID:21873648 PMID:22020378 PMID:23523949 PMID:27353299 PMID:28237877 PMID:30626778 PMID:30935902 PMID:31618080 PMID:32810592 PMID:35511042 PMID:38043637 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
increases expression multiple interactions |
ISO EXP |
Vitamin E results in increased expression of CASP9 mRNA Vitamin E inhibits the reaction [bioallethrin results in increased cleavage of CASP9 protein] [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dichlorvos results in increased activity of CASP9 protein]; [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP9 mRNA]; Vitamin E inhibits the reaction [Diazinon results in increased cleavage of CASP9 protein] |
CTD |
PMID:16973328 PMID:19244175 PMID:21628957 PMID:27353299 PMID:35511042 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions increases expression decreases activity affects expression |
ISO EXP |
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Air Pollutants, Occupational affects the expression of CAT protein]; [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Malathion results in increased activity of CAT protein]; [Ascorbic Acid co-treated with Vitamin E] results in increased expression of CAT mRNA; Vitamin E inhibits the reaction [Aluminum results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Dimethoate results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Malathion results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Oleic Acid results in decreased activity of CAT protein] Vitamin E results in increased expression of CAT protein [Curcumin co-treated with Vitamin E] inhibits the reaction [Thyroxine results in decreased expression of CAT mRNA]; [Selenium co-treated with Vitamin E] inhibits the reaction [Malathion results in decreased activity of CAT protein]; [Vitamin E co-treated with coenzyme Q10] inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; [Vitamin E co-treated with coenzyme Q10] results in increased activity of CAT protein; [Vitamin E co-treated with Curcumin] inhibits the reaction [Thyroxine results in decreased activity of CAT protein]; [Vitamin E co-treated with Quercetin] inhibits the reaction [Cyclosporine results in decreased activity of CAT protein]; [Vitamin E co-treated with Sodium Selenite] inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; [Vitamin E inhibits the reaction [Nanotubes, Carbon results in decreased activity of CAT protein]] which affects the abundance of Reactive Oxygen Species; [Zinc co-treated with Vitamin E co-treated with Ascorbic Acid co-treated with sodium arsenite] results in increased activity of CAT protein; Ginkgo biloba extract promotes the reaction [Vitamin E inhibits the reaction [endotoxin, Escherichia coli results in decreased activity of CAT protein]]; Vitamin E inhibits the reaction [Atrazine results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Cadmium results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Carbofuran results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [chromium hexavalent ion results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Cyclosporine results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Dimethoate results in increased activity of CAT protein]; Vitamin E inhibits the reaction [endotoxin, Escherichia coli results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Food Additives affects the activity of CAT protein]; Vitamin E inhibits the reaction [Formaldehyde results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Hexachlorobenzene results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Malathion results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Methoxychlor results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Nanotubes, Carbon results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Petroleum results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Potassium Dichromate results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Tetrachlorodibenzodioxin results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased expression of CAT protein]; Vitamin E promotes the reaction [Ginkgo biloba extract inhibits the reaction [endotoxin, Escherichia coli results in decreased activity of CAT protein]] Vitamin E results in decreased activity of CAT protein [Vitamin E co-treated with coenzyme Q10] inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Ethanol results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [fipronil results in decreased activity of CAT protein] Vitamin E affects the expression of CAT protein |
CTD |
PMID:11597945 PMID:11834209 PMID:11955947 PMID:12355564 PMID:14535831 PMID:15669049 PMID:15820619 PMID:16144695 PMID:16298753 PMID:16758767 PMID:16937016 PMID:17262218 PMID:17383094 PMID:17709913 PMID:17927767 PMID:18655177 PMID:19914224 PMID:19958828 PMID:20077558 PMID:20079796 PMID:20136348 PMID:20535553 PMID:21086752 PMID:21628957 PMID:21736874 PMID:21787585 PMID:22020378 PMID:22207723 PMID:23348005 PMID:23369933 PMID:23619517 PMID:24865641 PMID:25046308 PMID:25721553 PMID:29948670 PMID:30064338 More...
|
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cav1 |
caveolin 1 |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 protein] Vitamin E inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased phosphorylation of CAV1 protein] |
CTD |
PMID:12134086 PMID:35349355 |
|
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Cavin1 |
caveolae associated protein 1 |
multiple interactions increases expression |
ISO |
Vitamin E inhibits the reaction [Hydrogen Peroxide results in increased expression of CAVIN1 protein] Vitamin E results in increased expression of CAVIN1 mRNA |
CTD |
PMID:19244175 PMID:21705337 |
|
NCBI chr10:85,884,100...85,896,136
Ensembl chr10:85,889,036...85,896,120
|
|
G |
Cavin3 |
caveolae associated protein 3 |
increases expression |
ISO |
Vitamin E results in increased expression of CAVIN3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:159,826,549...159,828,138
Ensembl chr 1:159,826,549...159,828,161
|
|
G |
Cblb |
Cbl proto-oncogene B |
decreases expression |
ISO |
Vitamin E results in decreased expression of CBLB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:48,589,878...48,756,940
Ensembl chr11:48,592,703...48,756,839
|
|
G |
Cbx5 |
chromobox 5 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CBX5 mRNA Vitamin E results in decreased expression of CBX5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:134,333,165...134,376,102
Ensembl chr 7:134,331,335...134,375,022
|
|
G |
Cbx6 |
chromobox 6 |
increases expression |
ISO |
Vitamin E results in increased expression of CBX6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:111,372,979...111,383,026
Ensembl chr 7:111,372,980...111,383,091
|
|
G |
Cbx7 |
chromobox 7 |
increases expression |
ISO |
Vitamin E results in increased expression of CBX7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
|
|
G |
Cby1 |
chibby 1, beta catenin antagonist |
increases expression |
ISO |
Vitamin E results in increased expression of CBY1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:111,216,835...111,223,305
|
|
G |
Ccdc85b |
coiled-coil domain containing 85B |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of DIPA mRNA Vitamin E results in increased expression of DIPA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:202,763,645...202,764,660
Ensembl chr 1:202,763,631...202,764,703
|
|
G |
Cchcr1 |
coiled-coil alpha-helical rod protein 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CCHCR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:3,205,675...3,218,437
Ensembl chr20:3,205,676...3,218,308
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions increases expression |
ISO |
alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein]; Quercetin inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein] |
CTD |
PMID:19735175 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions |
ISO |
[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of CCL5 mRNA |
CTD |
PMID:16797527 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression multiple interactions affects expression |
ISO EXP |
Vitamin E results in increased expression of CCND1 mRNA Vitamin E inhibits the reaction [Curcumin results in decreased expression of CCND1 protein] Vitamin E affects the expression of CCND1 mRNA; Vitamin E affects the expression of CCND1 protein [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of CCND1 mRNA |
CTD |
PMID:11444866 PMID:16298738 PMID:19244175 PMID:30935902 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
increases expression |
ISO |
Vitamin E results in increased expression of CCND2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ccnd3 |
cyclin D3 |
affects expression |
EXP |
Vitamin E affects the expression of CCND3 mRNA |
CTD |
PMID:15370891 |
|
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
|
|
G |
Ccne1 |
cyclin E1 |
affects expression |
EXP |
Vitamin E affects the expression of CCNE1 mRNA |
CTD |
PMID:16298738 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccnl1 |
cyclin L1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CCNL1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:150,184,865...150,199,524
Ensembl chr 2:150,184,798...150,197,368
|
|
G |
Ccpg1 |
cell cycle progression 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CPR8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:73,719,960...73,752,437
Ensembl chr 8:73,719,955...73,752,430
|
|
G |
Ccs |
copper chaperone for superoxide dismutase |
increases expression |
ISO |
Vitamin E results in increased expression of CCS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:202,113,792...202,134,931
Ensembl chr 1:202,113,804...202,134,915
|
|
G |
Cd2bp2 |
Cd2 (cytoplasmic tail) binding protein 2 |
increases expression |
ISO |
Vitamin E results in increased expression of CD2BP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:181,809,399...181,815,269
Ensembl chr 1:181,809,406...181,813,448
|
|
G |
Cd44 |
CD44 molecule |
decreases expression |
ISO |
Vitamin E results in decreased expression of CD44 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd63 |
Cd63 molecule |
increases expression |
ISO |
Vitamin E results in increased expression of CD63 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:1,325,108...1,340,447
Ensembl chr 7:1,325,103...1,399,178
|
|
G |
Cd86 |
CD86 molecule |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [Dinitrochlorobenzene results in increased expression of CD86 protein]; Vitamin E inhibits the reaction [Ethylmercuric Chloride results in increased expression of CD86 protein]; Vitamin E inhibits the reaction [Thimerosal results in increased expression of CD86 protein] |
CTD |
PMID:20457211 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cd99 |
CD99 molecule (Xg blood group) |
increases expression |
ISO |
Vitamin E results in increased expression of CD99 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:54,418,239...54,422,882
|
|
G |
Cdc14b |
cell division cycle 14B |
decreases expression |
ISO |
Vitamin E results in decreased expression of CDC14B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:844,686...934,787
Ensembl chr17:844,685...933,235
|
|
G |
Cdc16 |
cell division cycle 16 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CDC16 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:75,773,026...75,796,586
Ensembl chr16:75,773,028...75,796,550
|
|
G |
Cdc25b |
cell division cycle 25B |
increases expression |
ISO |
Vitamin E results in increased expression of CDC25B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:118,407,127...118,417,272
Ensembl chr 3:118,407,128...118,417,272
|
|
G |
Cdc27 |
cell division cycle 27 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CDC27 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:89,400,720...89,449,816
Ensembl chr10:89,400,940...89,449,736
|
|
G |
Cdc42bpa |
CDC42 binding protein kinase alpha |
multiple interactions increases expression decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CDC42BPA mRNA Vitamin E results in increased expression of CDC42BPA mRNA Vitamin E results in decreased expression of CDC42BPA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:91,683,775...91,903,732
Ensembl chr13:91,684,007...91,903,732
|
|
G |
Cdh2 |
cadherin 2 |
multiple interactions |
EXP |
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CDH2 protein] |
CTD |
PMID:29940330 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdh3 |
cadherin 3 |
increases expression |
ISO |
Vitamin E results in increased expression of CDH3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:34,393,596...34,444,084
Ensembl chr19:34,393,727...34,444,084
|
|
G |
Cdk10 |
cyclin-dependent kinase 10 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CDK10 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:51,260,012...51,273,009
Ensembl chr19:51,261,356...51,269,078
|
|
G |
Cdk13 |
cyclin-dependent kinase 13 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CDK13 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:47,251,145...47,344,675
Ensembl chr17:47,251,163...47,341,721
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
increases expression |
ISO |
Vitamin E results in increased expression of CDK4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
affects expression multiple interactions |
EXP ISO |
Vitamin E affects the expression of CDKN1A mRNA Vitamin E inhibits the reaction [Curcumin results in decreased expression of CDKN1A protein] |
CTD |
PMID:16298738 PMID:30935902 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases expression |
ISO |
Vitamin E results in increased expression of CDKN1B protein |
CTD |
PMID:12352461 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cds1 |
CDP-diacylglycerol synthase 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CDS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:7,820,328...7,882,943
Ensembl chr14:7,820,351...7,882,681
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [Ethanol results in decreased activity of CEBPA protein]; Vitamin E inhibits the reaction [Ethanol results in decreased expression of CEBPA protein] |
CTD |
PMID:16737972 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
increases response to substance |
ISO |
CEBPB results in increased susceptibility to Vitamin E |
CTD |
PMID:9359698 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cep164 |
centrosomal protein 164 |
increases expression |
ISO |
Vitamin E results in increased expression of CEP164 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:46,070,901...46,134,511
Ensembl chr 8:46,071,076...46,134,336
|
|
G |
Cep170 |
centrosomal protein 170 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CEP170 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:88,669,672...88,754,011
Ensembl chr13:88,670,358...88,732,226
|
|
G |
Cep290 |
centrosomal protein 290 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CEP290 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:35,310,071...35,399,388
Ensembl chr 7:35,310,199...35,399,392
|
|
G |
Cep350 |
centrosomal protein 350 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CEP350 mRNA Vitamin E results in decreased expression of CEP350 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:68,023,327...68,164,478
Ensembl chr13:68,026,891...68,165,214
|
|
G |
Cep57 |
centrosomal protein 57 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CEP57 mRNA Vitamin E results in decreased expression of CEP57 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:10,669,588...10,689,257
Ensembl chr 8:10,669,590...10,689,249
|
|
G |
Cep97 |
centrosomal protein 97 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CEP97 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:44,683,503...44,711,471
Ensembl chr11:44,683,506...44,711,471
|
|
G |
Cerk |
ceramide kinase |
increases expression |
ISO |
Vitamin E results in increased expression of CERK mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:117,225,855...117,269,436
Ensembl chr 7:117,225,855...117,268,759
|
|
G |
Cert1 |
ceramide transporter 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CERT1 mRNA Vitamin E results in decreased expression of CERT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:27,882,546...27,987,090
Ensembl chr 2:27,882,555...27,987,074
|
|
G |
Ces1d |
carboxylesterase 1D |
increases expression |
ISO |
Vitamin E results in increased expression of CES1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
increases expression |
ISO |
Vitamin E results in increased expression of CFLAR mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Chd1 |
chromodomain helicase DNA binding protein 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CHD1 mRNA Vitamin E results in decreased expression of CHD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:56,661,743...56,729,119
Ensembl chr 1:56,664,054...56,728,125
|
|
G |
Chordc1 |
cysteine and histidine rich domain containing 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CHORDC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:15,374,356...15,398,436
Ensembl chr 8:15,374,471...15,399,162
|
|
G |
Chpf |
chondroitin polymerizing factor |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CHPF mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:76,963,178...76,967,878
Ensembl chr 9:76,963,184...76,967,878
|
|
G |
Chst3 |
carbohydrate sulfotransferase 3 |
increases expression |
ISO |
Vitamin E results in increased expression of CHST3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:28,114,386...28,152,046
Ensembl chr20:28,114,404...28,121,807
|
|
G |
Chst5 |
carbohydrate sulfotransferase 5 |
increases expression |
ISO |
Vitamin E results in increased expression of CHST6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:39,860,729...39,881,019
Ensembl chr19:39,860,501...39,881,064
|
|
G |
Ciao2b |
cytosolic iron-sulfur assembly component 2B |
increases expression |
ISO |
Vitamin E results in increased expression of CIAO2B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:344,194...346,068
Ensembl chr19:344,203...346,068
|
|
G |
Cib2 |
calcium and integrin binding family member 2 |
increases expression |
ISO |
Vitamin E results in increased expression of CIB2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:54,930,265...54,947,157
|
|
G |
Cirbp |
cold inducible RNA binding protein |
increases expression |
ISO |
Vitamin E results in increased expression of CIRBP mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818
|
|
G |
Ckap2 |
cytoskeleton associated protein 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CKAP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913
|
|
G |
Ckb |
creatine kinase B |
increases expression |
ISO |
Vitamin E results in increased expression of CKB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Ckm |
creatine kinase, M-type |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Diazinon results in increased activity of CKM protein] |
CTD |
PMID:23523949 |
|
NCBI chr 1:79,061,390...79,071,721
Ensembl chr 1:79,061,456...79,071,720
|
|
G |
Clcc1 |
chloride channel CLIC-like 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CLCC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:196,296,350...196,326,914
Ensembl chr 2:196,296,393...196,326,913
|
|
G |
Clcn3 |
chloride voltage-gated channel 3 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CLCN3 mRNA Vitamin E results in decreased expression of CLCN3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:29,127,152...29,200,133
Ensembl chr16:29,127,419...29,200,119
|
|
G |
Cldn4 |
claudin 4 |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [phoxim results in decreased expression of CLDN4 mRNA] |
CTD |
PMID:30003487 |
|
NCBI chr12:21,751,638...21,753,436
Ensembl chr12:21,751,331...21,753,436
|
|
G |
Clec3b |
C-type lectin domain family 3, member B |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of TNA mRNA Vitamin E results in increased expression of TNA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:122,810,120...122,815,837
Ensembl chr 8:122,810,149...122,815,835
|
|
G |
Clic1 |
chloride intracellular channel 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CLIC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:3,764,867...3,773,711
Ensembl chr20:3,761,461...3,773,712
|
|
G |
Clip1 |
CAP-GLY domain containing linker protein 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CLIP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:32,910,932...33,017,891
Ensembl chr12:32,910,977...33,017,884
|
|
G |
Cln3 |
CLN3 lysosomal/endosomal transmembrane protein, battenin |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CLN3 mRNA Vitamin E results in increased expression of CLN3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:181,156,071...181,169,458
Ensembl chr 1:181,156,073...181,167,434
|
|
G |
Cltb |
clathrin, light chain B |
increases expression |
ISO |
Vitamin E results in increased expression of CLTB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:10,001,512...10,019,201
Ensembl chr17:10,001,513...10,019,169
|
|
G |
Clu |
clusterin |
multiple interactions increases expression |
EXP ISO |
Vitamin E inhibits the reaction [Estradiol results in increased expression of CLU protein] Vitamin E results in increased expression of CLU mRNA |
CTD |
PMID:9037392 PMID:19244175 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Cmtr1 |
cap methyltransferase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CMTR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:7,722,729...7,782,579
Ensembl chr20:7,709,713...7,766,302
|
|
G |
Cngb1 |
cyclic nucleotide gated channel subunit beta 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CNGB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:9,726,595...9,791,111
Ensembl chr19:9,726,595...9,791,173
|
|
G |
Cnn1 |
calponin 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CNN1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:20,632,434...20,641,097
Ensembl chr 8:20,632,338...20,641,098
|
|
G |
Cnpy2 |
canopy FGF signaling regulator 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CNPY2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:748,877...754,352
Ensembl chr 7:749,008...755,519
|
|
G |
Cnpy3 |
canopy FGF signaling regulator 3 |
increases expression |
ISO |
Vitamin E results in increased expression of CNPY3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:14,233,478...14,247,847
Ensembl chr 9:14,233,428...14,247,831
|
|
G |
Cog4 |
component of oligomeric golgi complex 4 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of COG4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:38,820,478...38,854,803
Ensembl chr19:38,820,501...38,854,796
|
|
G |
Col18a1 |
collagen type XVIII alpha 1 chain |
increases expression |
ISO |
Vitamin E results in increased expression of COL18A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
EXP |
[silybin co-treated with Phosphatidylcholines co-treated with Vitamin E] inhibits the reaction [Dimethylnitrosamine results in increased expression of COL1A1 mRNA] |
CTD |
PMID:16169303 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [CYP2E1 protein results in increased expression of COL1A2 mRNA] |
CTD |
PMID:10498651 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
increases expression |
ISO |
Vitamin E results in increased expression of COL4A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
|
|
G |
Col4a3 |
collagen type IV alpha 3 chain |
decreases expression |
ISO |
Vitamin E results in decreased expression of COL4A3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:83,875,849...84,004,955
Ensembl chr 9:83,875,561...84,001,895
|
|
G |
Col6a2 |
collagen type VI alpha 2 chain |
increases expression |
ISO |
Vitamin E results in increased expression of COL6A2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564
|
|
G |
Col6a3 |
collagen type VI alpha 3 chain |
increases expression |
ISO |
Vitamin E results in increased expression of COL6A3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:91,361,578...91,439,434
Ensembl chr 9:91,361,583...91,439,471
|
|
G |
Colgalt2 |
collagen beta(1-O)galactosyltransferase 2 |
increases expression |
ISO |
Vitamin E results in increased expression of COLGALT2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:64,523,641...64,628,295
Ensembl chr13:64,523,658...64,627,549
|
|
G |
Commd3 |
COMM domain containing 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of COMMD3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:81,327,444...81,331,191
Ensembl chr17:81,327,405...81,331,177
|
|
G |
Cope |
COPI coat complex subunit epsilon |
increases expression |
ISO |
Vitamin E results in increased expression of COPE mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:19,114,871...19,125,076
Ensembl chr16:19,114,871...19,128,907
|
|
G |
Cops6 |
COP9 signalosome subunit 6 |
increases expression |
ISO |
Vitamin E results in increased expression of COPS6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:17,038,979...17,041,818
Ensembl chr12:17,038,979...17,046,371
|
|
G |
Copz2 |
COPI coat complex subunit zeta 2 |
increases expression |
ISO |
Vitamin E results in increased expression of COPZ2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:81,832,441...81,845,514
Ensembl chr10:81,832,418...81,845,514
|
|
G |
Coq9 |
coenzyme Q9 |
increases expression |
ISO |
Vitamin E results in increased expression of COQ9 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:10,166,948...10,179,976
Ensembl chr19:10,166,951...10,179,949
|
|
G |
Cox6a1 |
cytochrome c oxidase subunit 6A1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of COX6A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:41,261,983...41,265,037
Ensembl chr12:41,261,967...41,265,041
|
|
G |
Cpm |
carboxypeptidase M |
decreases expression |
ISO |
Vitamin E results in decreased expression of CPM mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:53,225,647...53,286,220
Ensembl chr 7:53,225,696...53,286,220
|
|
G |
Cpne1 |
copine 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CPNE1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:144,587,531...144,629,911
Ensembl chr 3:144,588,995...144,598,636
|
|
G |
Cpsf1 |
cleavage and polyadenylation specific factor 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CPSF1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:108,319,429...108,330,018
Ensembl chr 7:108,319,434...108,329,934
|
|
G |
Cr1l |
complement C3b/C4b receptor 1 like |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [Endosulfan results in decreased expression of CR1L mRNA] |
CTD |
PMID:23208437 |
|
NCBI chr13:106,606,952...106,660,442
Ensembl chr13:106,574,858...106,660,445
|
|
G |
Cr2 |
complement C3d receptor 2 |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [Endosulfan results in decreased expression of CR2 mRNA]; Vitamin E inhibits the reaction [Endosulfan results in decreased expression of CR2 protein] |
CTD |
PMID:23208437 |
|
NCBI chr13:106,678,579...106,716,595
Ensembl chr13:106,685,413...106,716,235
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CREB1 mRNA Vitamin E results in decreased expression of CREB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Creb3 |
cAMP responsive element binding protein 3 |
increases expression |
ISO |
Vitamin E results in increased expression of CREB3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:57,817,865...57,823,233
Ensembl chr 5:57,817,832...57,824,390
|
|
G |
Crebbp |
CREB binding protein |
decreases expression |
ISO |
Vitamin E results in decreased expression of CREBBP mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Crp |
C-reactive protein |
multiple interactions decreases expression |
ISO |
[Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Oleic Acid co-treated with Folic Acid co-treated with Vitamin B 6 co-treated with Vitamin E] results in decreased expression of CRP protein; [Vitamin E co-treated with Ascorbic Acid co-treated with Folic Acid co-treated with Riboflavin co-treated with Vitamin B 6 co-treated with Vitamin B 12] results in decreased expression of CRP protein; [Vitamin E co-treated with Ascorbic Acid] results in decreased expression of CRP protein Vitamin E inhibits the reaction [titanium dioxide results in increased expression of CRP protein] Vitamin E results in decreased expression of CRP protein |
CTD |
PMID:16517955 PMID:17237316 PMID:20370442 PMID:30626778 |
|
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Crybg2 |
crystallin beta-gamma domain containing 2 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CRYBG2 mRNA Vitamin E results in increased expression of CRYBG2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:146,286,406...146,318,417
Ensembl chr 5:146,286,925...146,323,666
|
|
G |
Csnk1a1 |
casein kinase 1, alpha 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CSNK1A1 mRNA Vitamin E results in decreased expression of CSNK1A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:55,017,049...55,050,184
Ensembl chr18:55,017,055...55,049,271
|
|
G |
Csnk1d |
casein kinase 1, delta |
decreases expression |
ISO |
Vitamin E results in decreased expression of CSNK1D mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:106,221,992...106,256,620
Ensembl chr10:106,221,992...106,256,614
|
|
G |
Csnk1e |
casein kinase 1, epsilon |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CSNK1E mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:110,983,322...111,006,926
Ensembl chr 7:110,983,318...111,006,794
|
|
G |
Csnk1g2 |
casein kinase 1, gamma 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CSNK1G2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:9,076,739...9,095,082
Ensembl chr 7:9,076,740...9,095,052
|
|
G |
Csnk1g3 |
casein kinase 1, gamma 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CSNK1G3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:47,299,547...47,386,538
Ensembl chr18:47,299,579...47,386,535
|
|
G |
Csnk2a1 |
casein kinase 2 alpha 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CSNK2A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:140,709,984...140,756,757
Ensembl chr 3:140,709,991...140,756,696
|
|
G |
Csnk2b |
casein kinase 2 beta |
increases expression |
ISO |
Vitamin E results in increased expression of CSNK2B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:3,700,363...3,705,331
Ensembl chr20:3,698,733...3,707,133
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CSPG4 mRNA Vitamin E results in increased expression of CSPG4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:57,264,962...57,300,010
Ensembl chr 8:57,264,962...57,300,010
|
|
G |
Cspp1 |
centrosome and spindle pole associated protein 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CSPP1 mRNA Vitamin E results in decreased expression of CSPP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:9,077,161...9,192,402
Ensembl chr 5:9,077,161...9,193,377
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CSRP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
|
|
G |
Cst3 |
cystatin C |
increases expression |
ISO |
Vitamin E results in increased expression of CST3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
|
|
G |
Ctbp1 |
C-terminal binding protein 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CTBP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:77,455,580...77,482,821
Ensembl chr14:77,455,696...77,482,821
|
|
G |
Ctbp2 |
C-terminal binding protein 2 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CTBP2 mRNA Vitamin E results in decreased expression of CTBP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:187,782,064...187,918,115
Ensembl chr 1:187,782,682...187,920,222
|
|
G |
Ctdnep1 |
CTD nuclear envelope phosphatase 1 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CTDNEP1 mRNA Vitamin E results in increased expression of CTDNEP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:54,704,367...54,713,781
Ensembl chr10:54,704,148...54,713,781
|
|
G |
Ctdspl |
CTD small phosphatase like |
increases expression |
ISO |
Vitamin E results in increased expression of CTDSPL mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:118,642,729...118,767,238
Ensembl chr 8:118,642,672...118,767,117
|
|
G |
Ctf1 |
cardiotrophin 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CTF1 protein |
CTD |
PMID:16507596 |
|
NCBI chr 1:182,328,035...182,336,346
Ensembl chr 1:182,328,090...182,333,335
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
EXP ISO |
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of and affects the localization of CTNNB1 protein]; [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CTNNB1 protein] Vitamin E inhibits the reaction [Curcumin results in decreased expression of CTNNB1 protein] |
CTD |
PMID:29940330 PMID:30935902 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctnnbl1 |
catenin, beta like 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CTNNBL1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:146,387,940...146,548,987
Ensembl chr 3:146,387,889...146,548,987
|
|
G |
Cttn |
cortactin |
decreases expression |
ISO |
Vitamin E results in decreased expression of CTTN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:199,599,710...199,635,254
Ensembl chr 1:199,599,710...199,635,164
|
|
G |
Cuedc2 |
CUE domain containing 2 |
increases expression |
ISO |
Vitamin E results in increased expression of CUEDC2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:245,192,057...245,200,594
Ensembl chr 1:245,192,063...245,200,339
|
|
G |
Cul3 |
cullin 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CUL3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:81,592,641...81,670,428
Ensembl chr 9:81,592,641...81,670,462
|
|
G |
Cul4a |
cullin 4A |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CUL4A mRNA Vitamin E results in increased expression of CUL4A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:76,385,298...76,422,316
Ensembl chr16:76,384,546...76,422,330
|
|
G |
Cutc |
cutC copper transporter |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CUTC mRNA Vitamin E results in decreased expression of CUTC mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:242,622,281...242,637,048
Ensembl chr 1:242,622,276...242,637,047
|
|
G |
Cux1 |
cut-like homeobox 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CUX1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:20,107,062...20,425,868
Ensembl chr12:20,107,311...20,425,866 Ensembl chr 4:20,107,311...20,425,866
|
|
G |
Cwh43 |
cell wall biogenesis 43 C-terminal homolog |
decreases expression |
ISO |
Vitamin E results in decreased expression of CWH43 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:34,754,279...34,800,530
Ensembl chr14:34,754,289...34,800,814
|
|
G |
Cxcr1 |
C-X-C motif chemokine receptor 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CXCR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:75,766,894...75,771,079
Ensembl chr 9:75,766,770...75,771,084
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
decreases expression |
ISO |
Vitamin E results in decreased expression of CYBA mRNA |
CTD |
PMID:15571180 |
|
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO EXP |
Vitamin E inhibits the reaction [cinnamaldehyde affects the localization of CYCS protein]; Vitamin E inhibits the reaction [phenethyl isothiocyanate affects the localization of CYCS protein] Vitamin E inhibits the reaction [Diazinon affects the localization of CYCS protein] |
CTD |
PMID:15566391 PMID:16054126 PMID:23523949 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyfip1 |
cytoplasmic FMR1 interacting protein 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CYFIP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:106,710,924...106,799,393
Ensembl chr 1:106,711,016...106,799,386
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [acetamiprid results in decreased expression of CYP11A mRNA]; Vitamin E inhibits the reaction [acetamiprid results in decreased expression of CYP11A protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of CYP11A1 protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of CYP11A1 mRNA] |
CTD |
PMID:16298753 PMID:17280759 PMID:28395332 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp11b3 |
cytochrome P450, family 11, subfamily b, polypeptide 3 |
multiple interactions decreases expression |
EXP |
Vitamin E inhibits the reaction [adrenocorticotropin zinc results in decreased expression of CYP11B2 mRNA]; Vitamin E promotes the reaction [adrenocorticotropin zinc results in decreased activity of CYP11B2 protein] Vitamin E results in decreased expression of CYP11B2 mRNA |
CTD |
PMID:10822027 PMID:28923436 |
|
NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
decreases expression multiple interactions |
EXP |
Vitamin E results in decreased expression of CYP19A1 mRNA Vitamin E inhibits the reaction [Doxorubicin results in decreased expression of CYP19A1 mRNA] |
CTD |
PMID:15084515 PMID:32810592 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
EXP |
Vitamin E results in increased expression of CYP1A1 mRNA |
CTD |
PMID:28923436 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
affects expression |
EXP |
Vitamin E inhibits the reaction [nitroglycerine decreases Cyp1a2 protein expression in rat heart] |
RGD |
PMID:16520233 |
RGD:401900296 |
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
ISO EXP |
Vitamin E inhibits the reaction [[CYP2E1 protein co-treated with Paraquat] results in increased expression of KLF6 protein]; Vitamin E inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; Vitamin E inhibits the reaction [Arachidonic Acid promotes the reaction [CYP2E1 protein results in increased expression of KLF6 mRNA]]; Vitamin E inhibits the reaction [CYP2E1 protein promotes the reaction [Arachidonic Acid results in increased expression of KLF6 mRNA alternative form]]; Vitamin E inhibits the reaction [CYP2E1 protein results in increased expression of COL1A2 mRNA] Vitamin E inhibits the reaction [decamethrin results in increased expression of CYP2E1 mRNA] |
CTD |
PMID:10498651 PMID:22486562 PMID:25439240 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CYP3A4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CYP3A5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Daam1 |
dishevelled associated activator of morphogenesis 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of DAAM1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:90,389,544...90,550,114
Ensembl chr 6:90,389,688...90,550,114
|
|
G |
Daam2 |
dishevelled associated activator of morphogenesis 2 |
increases expression |
ISO |
Vitamin E results in increased expression of DAAM2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:11,428,913...11,546,982
Ensembl chr 9:11,428,724...11,545,497
|
|
G |
Dact1 |
dishevelled-binding antagonist of beta-catenin 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of DACT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:89,790,676...89,818,254
Ensembl chr 6:89,790,644...89,817,906
|
|
G |
Dad1 |
defender against cell death 1 |
multiple interactions |
EXP |
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of DAD1 mRNA |
CTD |
PMID:11444866 |
|
NCBI chr15:27,677,286...27,697,120
Ensembl chr15:27,677,268...27,697,347
|
|
G |
Dapk3 |
death-associated protein kinase 3 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of DAPK3 mRNA Vitamin E results in increased expression of DAPK3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:8,524,182...8,532,552
Ensembl chr 7:8,524,183...8,532,558
|
|
G |
Dcaf8 |
DDB1 and CUL4 associated factor 8 |
increases expression |
ISO |
Vitamin E results in increased expression of DCAF8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:84,609,838...84,667,025
Ensembl chr13:84,610,248...84,669,726
|
|
G |
Dcn |
decorin |
increases expression |
ISO |
Vitamin E results in increased expression of DCN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
|
|
G |
Dctn3 |
dynactin subunit 3 |
increases expression |
ISO |
Vitamin E results in increased expression of DCTN3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:56,881,085...56,889,041
Ensembl chr 5:56,881,085...56,889,102
|
|
G |
Ddah2 |
DDAH family member 2, ADMA-independent |
increases expression |
ISO |
Vitamin E results in increased expression of DDAH2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:3,761,460...3,764,718
Ensembl chr20:3,761,465...3,764,511
|
|
G |
Ddost |
dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit |
increases expression |
ISO |
Vitamin E results in increased expression of DDOST mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:150,522,297...150,529,413
Ensembl chr 5:150,522,242...150,529,413
|
|
G |
Ddx17 |
DEAD-box helicase 17 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of DDX17 mRNA Vitamin E results in decreased expression of DDX17 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:111,091,127...111,109,353
Ensembl chr 7:111,089,445...111,109,193
|
|
G |
Ddx18 |
DEAD-box helicase 18 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of DDX18 mRNA Vitamin E results in decreased expression of DDX18 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:32,729,697...32,743,161
Ensembl chr13:32,729,700...32,743,161
|
|
G |
Ddx24 |
DEAD-box helicase 24 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of DDX24 mRNA Vitamin E results in decreased expression of DDX24 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:122,564,767...122,582,032
Ensembl chr 6:122,564,767...122,581,927
|
|
G |
Ddx39b |
DExD-box helicase 39B |
increases expression decreases expression |
ISO |
Vitamin E results in increased expression of DDX39B mRNA Vitamin E results in decreased expression of DDX39B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:3,547,702...3,585,064
Ensembl chr20:3,572,056...3,584,996
|
|
G |
Ddx41 |
DEAD-box helicase 41 |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of DDX41 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of DDX41 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:9,102,926...9,108,415
Ensembl chr17:9,103,010...9,108,415
|
|
G |
Dedd |
death effector domain-containing |
increases expression |
ISO |
Vitamin E results in increased expression of DEDD mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:83,755,874...83,769,982
Ensembl chr13:83,756,108...83,769,332
|
|
G |
Dennd1b |
DENN domain containing 1B |
decreases expression |
ISO |
Vitamin E results in decreased expression of DENND1B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:50,545,324...50,772,922
Ensembl chr13:50,545,836...50,770,601
|
|
G |
Dennd2b |
DENN domain containing 2B |
increases expression |
ISO |
Vitamin E results in increased expression of DENND2B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:163,544,075...163,734,736
Ensembl chr 1:163,544,074...163,694,680
|
|
G |
Dennd2d |
DENN domain containing 2D |
decreases expression |
ISO |
Vitamin E results in decreased expression of DENND2D mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:193,973,231...193,992,275
Ensembl chr 2:193,973,231...193,992,270
|
|
G |
Dennd4a |
DENN domain containing 4A |
decreases expression |
ISO |
Vitamin E results in decreased expression of DENND4A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:65,322,920...65,436,331
Ensembl chr 8:65,322,941...65,436,330
|
|
G |
Dennd5a |
DENN domain containing 5A |
increases expression |
ISO |
Vitamin E results in increased expression of DENND5A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:163,928,183...163,994,207
Ensembl chr 1:163,928,183...163,994,316
|
|
G |
Des |
desmin |
increases expression |
ISO |
Vitamin E results in increased expression of DES mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:76,850,979...76,858,695
Ensembl chr 9:76,850,982...76,858,699
|
|
G |
Dgcr8 |
DGCR8 microprocessor complex subunit |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of DGCR8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:82,704,673...82,737,251
Ensembl chr11:82,704,729...82,737,242
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
affects expression |
EXP |
Vitamin E affects the expression of DHCR7 mRNA |
CTD |
PMID:15370891 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dhodh |
dihydroorotate dehydrogenase |
decreases expression |
ISO |
Vitamin E results in decreased expression of DHODH mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:37,551,858...37,573,327
Ensembl chr19:37,558,177...37,591,654
|
|
G |
Dhps |
deoxyhypusine synthase |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of DHPS mRNA [Selenium co-treated with Vitamin E] results in increased expression of DHPS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:23,082,454...23,086,544
Ensembl chr19:23,082,448...23,086,881
|
|
G |
Dhrs1 |
dehydrogenase/reductase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of DHRS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:29,236,522...29,243,807
Ensembl chr15:29,236,522...29,243,838
|
|
G |
Dhrs4 |
dehydrogenase/reductase 4 |
increases expression |
ISO |
Vitamin E results in increased expression of DHRS4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:28,966,544...28,978,135
Ensembl chr15:28,966,553...28,978,127
|
|
G |
Dhx9 |
DExH-box helicase 9 |
decreases expression |
ISO |
Vitamin E results in decreased expression of DHX9 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:65,602,322...65,639,098
Ensembl chr13:65,602,323...65,639,069
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [cinnamaldehyde affects the localization of DIABLO protein]; Vitamin E inhibits the reaction [phenethyl isothiocyanate affects the localization of DIABLO protein] |
CTD |
PMID:15566391 PMID:16054126 |
|
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Dicer1 |
dicer 1 ribonuclease III |
decreases expression |
ISO |
Vitamin E results in decreased expression of DICER1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:123,627,529...123,692,278
Ensembl chr 6:123,631,250...123,693,965
|
|
G |
Dio2 |
iodothyronine deiodinase 2 |
increases expression |
ISO |
Vitamin E results in increased expression of DIO2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
|
|
G |
Dlst |
dihydrolipoamide S-succinyltransferase |
increases expression |
ISO |
Vitamin E results in increased expression of DLST mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:104,758,511...104,783,296
Ensembl chr 6:104,758,631...104,783,296
|
|
G |
Dmtf1 |
cyclin D binding myb-like transcription factor 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of DMTF1 mRNA Vitamin E results in decreased expression of DMTF1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:24,909,937...24,950,786
Ensembl chr 4:24,910,534...24,950,967
|
|
G |
Dnaja3 |
DnaJ heat shock protein family (Hsp40) member A3 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of DNAJA3 mRNA Vitamin E results in decreased expression of DNAJA3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:10,854,732...10,880,171
Ensembl chr10:10,854,732...10,880,161
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
decreases expression |
ISO |
Vitamin E results in decreased expression of DNAJB4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
|
|
G |
Dnajc2 |
DnaJ heat shock protein family (Hsp40) member C2 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of DNAJC2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of DNAJC2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:13,270,239...13,297,438
Ensembl chr 4:13,270,191...13,297,431
|
|
G |
Dnajc3 |
DnaJ heat shock protein family (Hsp40) member C3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of DNAJC3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:96,025,605...96,068,585
Ensembl chr15:96,025,624...96,065,181
|
|
G |
Dnajc7 |
DnaJ heat shock protein family (Hsp40) member C7 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of DNAJC7 mRNA Vitamin E results in increased expression of DNAJC7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:85,518,637...85,555,079
Ensembl chr10:85,518,621...85,555,575
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of DNMT1 mRNA |
CTD |
PMID:29854080 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
decreases expression |
ISO |
Vitamin E results in decreased expression of DNMT3A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
|
|
G |
Dnph1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of DNPH1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:14,481,296...14,484,034
Ensembl chr 9:14,481,066...14,484,022
|
|
G |
Dock1 |
dedicator of cyto-kinesis 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of DOCK1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:189,467,143...189,983,777
Ensembl chr 1:189,467,143...189,983,768
|
|
G |
Dohh |
deoxyhypusine hydroxylase |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of DOHH mRNA Vitamin E results in increased expression of DOHH mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:8,321,466...8,326,305
Ensembl chr 7:8,321,466...8,326,289
|
|
G |
Dok1 |
docking protein 1 |
increases expression |
ISO |
Vitamin E results in increased expression of DOK1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:115,537,453...115,540,464
Ensembl chr 4:115,537,462...115,540,465
|
|
G |
Dpt |
dermatopontin |
increases expression |
ISO |
Vitamin E results in increased expression of DPT mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:77,123,224...77,151,646
Ensembl chr13:77,123,115...77,151,639
|
|
G |
Dpysl3 |
dihydropyrimidinase-like 3 |
increases expression |
ISO |
Vitamin E results in increased expression of DPYSL3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:35,374,427...35,480,228
Ensembl chr18:35,377,181...35,480,157
|
|
G |
Dr1 |
down-regulator of transcription 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of DR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:1,458,223...1,469,578
Ensembl chr14:1,458,223...1,469,638
|
|
G |
Drg2 |
developmentally regulated GTP binding protein 2 |
increases expression |
ISO |
Vitamin E results in increased expression of DRG2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:45,255,512...45,269,971
Ensembl chr10:45,255,507...45,269,969
|
|
G |
Dsc2 |
desmocollin 2 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of DSC2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of DSC2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:11,450,392...11,482,476
Ensembl chr18:11,450,390...11,482,392
|
|
G |
Dxo |
decapping exoribonuclease |
increases expression |
ISO |
Vitamin E results in increased expression of DXO mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:3,993,322...3,995,484
Ensembl chr20:3,993,327...3,995,494
|
|
G |
Dync1h1 |
dynein cytoplasmic 1 heavy chain 1 |
increases expression |
ISO |
Vitamin E results in increased expression of DYNC1H1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:129,615,208...129,680,888
Ensembl chr 6:129,609,397...129,680,883
|
|
G |
E2f6 |
E2F transcription factor 6 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of E2F6 mRNA Vitamin E results in decreased expression of E2F6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:39,592,224...39,608,685
Ensembl chr 6:39,592,228...39,608,683
|
|
G |
Echdc2 |
enoyl CoA hydratase domain containing 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ECHDC2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:122,915,874...122,934,860
Ensembl chr 5:122,916,134...122,934,859
|
|
G |
Ecsit |
ECSIT signaling integrator |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of ECSIT mRNA [Selenium co-treated with Vitamin E] results in increased expression of ECSIT mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:20,605,583...20,618,453
Ensembl chr 8:20,605,583...20,618,390
|
|
G |
Eda |
ectodysplasin-A |
decreases expression |
ISO |
Vitamin E results in decreased expression of EDA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:65,078,454...65,480,172
Ensembl chr X:65,078,673...65,480,172
|
|
G |
Edem3 |
ER degradation enhancing alpha-mannosidase like protein 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of EDEM3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:63,858,282...63,920,538
Ensembl chr13:63,858,716...63,920,523
|
|
G |
Edf1 |
endothelial differentiation-related factor 1 |
increases expression |
ISO |
Vitamin E results in increased expression of EDF1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:8,377,058...8,381,363
Ensembl chr 3:8,366,613...8,381,363
|
|
G |
Ednra |
endothelin receptor type A |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of EDNRA mRNA Vitamin E results in decreased expression of EDNRA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
|
|
G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of EEF1A2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of EEF1A2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:168,265,893...168,275,071
Ensembl chr 3:168,195,357...168,275,071
|
|
G |
Eef1d |
eukaryotic translation elongation factor 1 delta |
increases expression |
ISO |
Vitamin E results in increased expression of EEF1D mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:107,581,930...107,596,735
Ensembl chr 7:107,581,930...107,608,799
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
multiple interactions increases expression |
EXP |
Vitamin E analog inhibits the reaction [cumene hydroperoxide results in decreased expression of EEF2 protein] Vitamin E analog results in increased expression of EEF2 protein |
CTD |
PMID:17510559 |
|
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
|
|
G |
Efcab14 |
EF-hand calcium binding domain 14 |
increases expression |
ISO |
Vitamin E results in increased expression of EFCAB14 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:129,218,139...129,258,628
Ensembl chr 5:129,218,424...129,258,625
|
|
G |
Efemp2 |
EGF containing fibulin extracellular matrix protein 2 |
increases expression |
ISO |
Vitamin E results in increased expression of EFEMP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:202,781,692...202,789,784
Ensembl chr 1:202,781,665...202,789,414
|
|
G |
Efhc1 |
EF-hand domain containing 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of EFHC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:23,375,815...23,414,283
Ensembl chr 9:23,375,840...23,414,283
|
|
G |
Efhd2 |
EF-hand domain family, member D2 |
increases expression |
ISO |
Vitamin E results in increased expression of EFHD2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:154,160,945...154,176,980
Ensembl chr 5:154,160,946...154,176,980
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases expression |
ISO |
Vitamin E results in decreased expression of EGFR mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egln2 |
egl-9 family hypoxia-inducible factor 2 |
increases expression |
ISO |
Vitamin E results in increased expression of EGLN2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:82,451,554...82,459,809
Ensembl chr 1:82,451,555...82,459,751
|
|
G |
Egr1 |
early growth response 1 |
decreases expression multiple interactions |
ISO EXP |
Vitamin E results in decreased expression of EGR1 mRNA [Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of EGR1 mRNA |
CTD |
PMID:11444866 PMID:19244175 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Ehbp1 |
EH domain binding protein 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of EHBP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:96,093,327...96,380,502
Ensembl chr14:96,093,327...96,345,332
|
|
G |
Ehd2 |
EH-domain containing 2 |
increases expression |
ISO |
Vitamin E results in increased expression of EHD2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:76,639,568...76,658,747
Ensembl chr 1:76,637,482...76,658,783
|
|
G |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of EIF2AK2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:16,189,000...16,224,972
Ensembl chr 6:16,188,979...16,224,971
|
|
G |
Eif2b2 |
eukaryotic translation initiation factor 2B subunit beta |
increases expression |
ISO |
Vitamin E results in increased expression of EIF2B2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:104,866,926...104,873,351
Ensembl chr 6:104,866,753...104,873,353
|
|
G |
Eif3a |
eukaryotic translation initiation factor 3, subunit A |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of EIF3A mRNA Vitamin E results in decreased expression of EIF3A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:259,902,767...259,932,976
Ensembl chr 1:259,902,680...259,932,976
|
|
G |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
increases expression |
ISO |
Vitamin E results in increased expression of EIF3B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:14,196,403...14,220,865
Ensembl chr12:14,196,403...14,220,886
|
|
G |
Eif3k |
eukaryotic translation initiation factor 3, subunit K |
increases expression |
ISO |
Vitamin E results in increased expression of EIF3K mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:84,260,127...84,270,051
Ensembl chr 1:84,259,673...84,270,302
|
|
G |
Eif4a1 |
eukaryotic translation initiation factor 4A1 |
increases expression |
ISO |
Vitamin E results in increased expression of EIF4A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:54,384,345...54,389,855
Ensembl chr10:54,384,347...54,389,858
|
|
G |
Eif4ebp2 |
eukaryotic translation initiation factor 4E binding protein 2 |
increases expression |
ISO |
Vitamin E results in increased expression of EIF4EBP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:29,379,444...29,400,110
Ensembl chr20:29,382,668...29,399,946
|
|
G |
Eif4g1 |
eukaryotic translation initiation factor 4 gamma 1 |
multiple interactions increases expression decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of EIF4G1 mRNA Vitamin E results in increased expression of EIF4G1 mRNA Vitamin E results in decreased expression of EIF4G1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:80,221,919...80,241,958
Ensembl chr11:80,221,919...80,241,941
|
|
G |
Eif5 |
eukaryotic translation initiation factor 5 |
decreases expression |
ISO |
Vitamin E results in decreased expression of EIF5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:130,589,162...130,597,656
Ensembl chr 6:130,589,143...130,597,656
|
|
G |
Eif5a |
eukaryotic translation initiation factor 5A |
multiple interactions increases expression decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of EIF5A mRNA Vitamin E results in increased expression of EIF5A mRNA Vitamin E results in decreased expression of EIF5A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:54,640,104...54,644,845
Ensembl chr10:54,640,024...54,644,656
|
|
G |
Eif5b |
eukaryotic translation initiation factor 5B |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of IF2 mRNA Vitamin E results in decreased expression of IF2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:40,222,769...40,277,482
Ensembl chr 9:40,222,898...40,277,482
|
|
G |
Eif6 |
eukaryotic translation initiation factor 6 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of EIF6 mRNA Vitamin E results in increased expression of EIF6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:144,325,038...144,331,396
Ensembl chr 3:144,325,036...144,331,401
|
|
G |
Elf1 |
E74 like ETS transcription factor 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ELF1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:54,890,644...54,986,721
Ensembl chr15:54,865,616...54,986,699
|
|
G |
Elk1 |
ETS transcription factor ELK1 |
increases phosphorylation |
ISO |
Vitamin E results in increased phosphorylation of ELK1 protein |
CTD |
PMID:11522656 |
|
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
|
|
G |
Eloa |
elongin A |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ELOA mRNA Vitamin E results in decreased expression of ELOA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:148,231,600...148,246,760
Ensembl chr 5:148,231,596...148,246,765
|
|
G |
Emc6 |
ER membrane protein complex subunit 6 |
increases expression |
ISO |
Vitamin E results in increased expression of EMC6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:57,794,072...57,795,671
Ensembl chr10:57,793,685...57,796,217
|
|
G |
Emc9 |
ER membrane protein complex subunit 9 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of EMC9 mRNA Vitamin E results in increased expression of EMC9 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:29,071,881...29,076,098
Ensembl chr15:29,071,883...29,076,098
|
|
G |
Emilin1 |
elastin microfibril interfacer 1 |
increases expression |
ISO |
Vitamin E results in increased expression of EMILIN1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:25,455,974...25,463,713
Ensembl chr 6:25,445,298...25,463,698
|
|
G |
Eml2 |
EMAP like 2 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of EML2 mRNA Vitamin E results in increased expression of EML2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:78,827,595...78,859,342
Ensembl chr 1:78,828,080...78,859,341
|
|
G |
Emp3 |
epithelial membrane protein 3 |
increases expression |
ISO |
Vitamin E results in increased expression of EMP3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:96,388,651...96,391,946
Ensembl chr 1:96,388,652...96,391,988
|
|
G |
Emsy |
EMSY transcriptional repressor, BRCA2 interacting |
decreases expression |
ISO |
Vitamin E results in decreased expression of EMSY mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:152,881,485...152,960,420
Ensembl chr 1:152,883,992...152,953,528
|
|
G |
Endog |
endonuclease G |
increases expression |
ISO |
Vitamin E results in increased expression of ENDOG mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
|
|
G |
Eno1 |
enolase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of ENO1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336 Ensembl chr 3:160,719,951...160,731,336
|
|
G |
Eno2 |
enolase 2 |
increases expression |
ISO |
Vitamin E results in increased expression of ENO2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Entpd1 |
ectonucleoside triphosphate diphosphohydrolase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of ENTPD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:239,425,515...239,552,323
Ensembl chr 1:239,425,430...239,552,317
|
|
G |
Entpd5 |
ectonucleoside triphosphate diphosphohydrolase 5 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ENTPD5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:104,019,095...104,055,311
Ensembl chr 6:104,019,185...104,055,530
|
|
G |
Epb41l2 |
erythrocyte membrane protein band 4.1-like 2 |
increases expression |
ISO |
Vitamin E results in increased expression of EPB41L2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:19,863,010...20,037,795
Ensembl chr 1:19,863,009...20,037,721
|
|
G |
Epn2 |
epsin 2 |
increases expression |
ISO |
Vitamin E results in increased expression of EPN2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:46,197,785...46,259,673
Ensembl chr10:46,197,785...46,259,642
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ERBB2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
increases expression |
ISO |
Vitamin E results in increased expression of ERCC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Ercc3 |
ERCC excision repair 3, TFIIH core complex helicase subunit |
increases expression |
ISO |
Vitamin E results in increased expression of ERCC3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:23,883,613...23,914,326
Ensembl chr18:23,883,580...23,914,329
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions affects expression |
EXP |
Vitamin E affects the reaction [Doxorubicin affects the expression of ESR1 mRNA] Vitamin E affects the expression of ESR1 mRNA |
CTD |
PMID:32810592 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esrp2 |
epithelial splicing regulatory protein 2 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of ESRP2 mRNA [Selenium co-treated with Vitamin E] results in increased expression of ESRP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:34,034,559...34,041,726
Ensembl chr19:34,034,559...34,041,726
|
|
G |
Ess2 |
ess-2 splicing factor homolog |
increases expression |
ISO |
Vitamin E results in increased expression of ESS2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:83,075,893...83,085,849
Ensembl chr11:83,075,925...83,084,846
|
|
G |
Ets2 |
ETS proto-oncogene 2, transcription factor |
decreases expression |
ISO |
Vitamin E results in decreased expression of ETS2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
|
|
G |
Evi5 |
ecotropic viral integration site 5 |
decreases expression |
ISO |
Vitamin E results in decreased expression of EVI5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:1,875,601...2,021,678
Ensembl chr14:1,875,647...2,021,678
|
|
G |
Evl |
Enah/Vasp-like |
increases expression |
ISO |
Vitamin E results in increased expression of EVL mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:127,473,119...127,594,342
Ensembl chr 6:127,474,543...127,594,344
|
|
G |
Ewsr1 |
EWS RNA-binding protein 1 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of EWSR1 mRNA Vitamin E results in increased expression of EWSR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:79,965,365...79,994,108
Ensembl chr14:79,965,368...79,994,544
|
|
G |
Exoc3 |
exocyst complex component 3 |
increases expression |
ISO |
Vitamin E results in increased expression of SEC6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:29,091,298...29,122,056
Ensembl chr 1:29,091,294...29,122,045
|
|
G |
Exosc4 |
exosome component 4 |
increases expression |
ISO |
Vitamin E results in increased expression of EXOSC4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:108,047,831...108,050,573
Ensembl chr 7:108,047,831...108,050,573
|
|
G |
Ext1 |
exostosin glycosyltransferase 1 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of EXT1 mRNA Vitamin E results in increased expression of EXT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:84,375,769...84,654,625
Ensembl chr 7:84,375,784...84,655,357
|
|
G |
Eya2 |
EYA transcriptional coactivator and phosphatase 2 |
increases expression |
ISO |
Vitamin E results in increased expression of EYA2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:154,335,598...154,519,006
Ensembl chr 3:154,335,400...154,518,793
|
|
G |
Ezh1 |
enhancer of zeste 1 polycomb repressive complex 2 subunit |
increases expression |
ISO |
Vitamin E results in increased expression of EZH1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:86,126,023...86,162,001
Ensembl chr10:86,126,015...86,161,921
|
|
G |
Ezr |
ezrin |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of EZR mRNA [Selenium co-treated with Vitamin E] results in decreased expression of EZR mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
|
|
G |
F10 |
coagulation factor X |
increases expression |
ISO |
Vitamin E results in increased expression of F10 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141
|
|
G |
F2 |
coagulation factor II, thrombin |
multiple interactions |
ISO |
Vitamin E results in decreased expression of and results in decreased activity of F2 protein |
CTD |
PMID:10216089 |
|
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of F2R mRNA [Selenium co-treated with Vitamin E] results in increased expression of F2R mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
|
|
G |
F3 |
coagulation factor III, tissue factor |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [Copper results in increased activity of F3 protein]; Vitamin E inhibits the reaction [Norepinephrine results in increased expression of F3 mRNA]; Vitamin E results in decreased expression of and results in decreased activity of F3 protein |
CTD |
PMID:7600656 PMID:10216089 PMID:23114885 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Fabp3 |
fatty acid binding protein 3 |
increases expression |
ISO |
Vitamin E results in increased expression of FABP3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:142,651,962...142,658,707
Ensembl chr 5:142,651,956...142,658,718
|
|
G |
Faim |
Fas apoptotic inhibitory molecule |
increases expression |
ISO |
Vitamin E results in increased expression of FAIM mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:99,543,877...99,569,499
Ensembl chr 8:99,542,405...99,560,562
|
|
G |
Fam107a |
family with sequence similarity 107, member A |
increases expression |
ISO |
Vitamin E results in increased expression of FAM107A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:16,608,362...16,630,398
Ensembl chr15:16,607,205...16,630,396
|
|
G |
Fam111a |
FAM111 trypsin like peptidase A |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of FAM111A mRNA [Selenium co-treated with Vitamin E] results in decreased expression of FAM111A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:209,640,865...209,656,551
Ensembl chr 1:209,640,953...209,656,547
|
|
G |
Fam149a |
family with sequence similarity 149, member A |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of FAM149A mRNA Vitamin E results in decreased expression of FAM149A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:46,855,377...46,914,553
Ensembl chr16:46,854,635...46,912,066
|
|
G |
Fam174c |
family with sequence similarity 174 member C |
decreases expression |
ISO |
Vitamin E results in decreased expression of FAM174C mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:9,531,995...9,533,705
|
|
G |
Fam222b |
family with sequence similarity 222, member B |
decreases expression |
ISO |
Vitamin E results in decreased expression of FAM222B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:62,986,571...63,052,350
Ensembl chr10:62,986,571...63,052,350
|
|
G |
Fam3a |
FAM3 metabolism regulating signaling molecule A |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of FAM3A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:152,166,716...152,175,327
Ensembl chr X:152,165,535...152,175,362
|
|
G |
Fam53b |
family with sequence similarity 53, member B |
increases expression |
ISO |
Vitamin E results in increased expression of FAM53B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:187,500,061...187,591,186
Ensembl chr 1:187,500,066...187,591,186
|
|
G |
Fam89b |
family with sequence similarity 89, member B |
increases expression |
ISO |
Vitamin E results in increased expression of FAM89B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:203,015,772...203,017,890
Ensembl chr 1:203,015,773...203,017,367
|
|
G |
Farsa |
phenylalanyl-tRNA synthetase subunit alpha |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of FARSA mRNA Vitamin E results in increased expression of FARSA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:23,291,409...23,300,985
Ensembl chr19:23,268,869...23,300,980
|
|
G |
Fastkd3 |
FAST kinase domains 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FASTKD3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:34,858,342...34,866,988
Ensembl chr 1:34,858,219...34,866,973
|
|
G |
Fat4 |
FAT atypical cadherin 4 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FAT4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:121,927,266...122,056,700
Ensembl chr 2:121,927,942...122,056,707
|
|
G |
Fbln1 |
fibulin 1 |
increases expression |
ISO |
Vitamin E results in increased expression of FBLN1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
|
|
G |
Fbxl7 |
F-box and leucine-rich repeat protein 7 |
increases expression |
ISO |
Vitamin E results in increased expression of FBXL7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:77,139,775...77,509,223
Ensembl chr 2:77,140,826...77,509,223
|
|
G |
Fbxo17 |
F-box protein 17 |
increases expression |
ISO |
Vitamin E results in increased expression of FBXO17 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:84,002,276...84,024,455
Ensembl chr 1:84,002,267...84,024,453
|
|
G |
Fbxo28 |
F-box protein 28 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of FBXO28 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:93,995,993...94,021,464
Ensembl chr13:93,995,996...94,021,464
|
|
G |
Fbxo31 |
F-box protein 31 |
increases expression |
ISO |
Vitamin E results in increased expression of FBXO31 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:49,624,813...49,656,052
Ensembl chr19:49,627,686...49,656,010
|
|
G |
Fbxw2 |
F-box and WD repeat domain containing 2 |
increases expression |
ISO |
Vitamin E results in increased expression of FBXW2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:18,088,859...18,114,387
Ensembl chr 3:18,088,865...18,114,381
|
|
G |
Fech |
ferrochelatase |
decreases expression |
ISO |
Vitamin E results in decreased expression of FECH mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
|
|
G |
Fermt1 |
FERM domain containing kindlin 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FERMT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:120,171,301...120,213,555
Ensembl chr 3:120,171,561...120,213,555
|
|
G |
Ferry3 |
FERRY endosomal RAB5 effector complex subunit 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FERRY3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:159,772,693...159,809,322
Ensembl chr 4:159,772,786...159,806,382
|
|
G |
Fgg |
fibrinogen gamma chain |
multiple interactions |
EXP |
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of FGG mRNA |
CTD |
PMID:11444866 |
|
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
|
|
G |
Fibp |
FGF1 intracellular binding protein |
increases expression |
ISO |
Vitamin E results in increased expression of FIBP mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:202,768,065...202,772,405
Ensembl chr 1:202,768,078...202,772,399
|
|
G |
Fig4 |
FIG4 phosphoinositide 5-phosphatase |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of FIG4 mRNA Vitamin E results in decreased expression of FIG4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:44,600,603...44,724,047
Ensembl chr20:44,600,603...44,723,844
|
|
G |
Fis1 |
fission, mitochondrial 1 |
increases expression |
ISO |
Vitamin E results in increased expression of FIS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:19,708,560...19,723,392
Ensembl chr12:19,708,558...19,723,377
|
|
G |
Fkbp1a |
FKBP prolyl isomerase 1A |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of FKBP1A mRNA Vitamin E results in increased expression of FKBP1A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
|
|
G |
Flii |
FLII, actin remodeling protein |
increases expression |
ISO |
Vitamin E results in increased expression of FLII mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:45,394,032...45,408,051
Ensembl chr10:45,394,032...45,407,970
|
|
G |
Flna |
filamin A |
increases expression |
ISO |
Vitamin E results in increased expression of FLNA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:152,007,758...152,034,266
Ensembl chr X:152,007,758...152,031,052
|
|
G |
Flot1 |
flotillin 1 |
increases expression |
ISO |
Vitamin E results in increased expression of FLOT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:2,917,864...2,927,993
Ensembl chr20:2,917,137...2,927,978
|
|
G |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FLRT3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:127,994,491...128,008,137
Ensembl chr 3:127,994,226...128,007,841
|
|
G |
Fmo5 |
flavin containing dimethylaniline monoxygenase 5 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of FMO5 mRNA Vitamin E results in decreased expression of FMO5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:185,197,184...185,249,699
Ensembl chr 2:185,222,204...185,249,693
|
|
G |
Fnbp1 |
formin binding protein 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FNBP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:14,309,067...14,424,378
Ensembl chr 3:14,309,640...14,424,881
|
|
G |
Fnbp4 |
formin binding protein 4 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FNBP4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:76,733,012...76,763,077
Ensembl chr 3:76,733,027...76,763,079
|
|
G |
Folh1 |
folate hydrolase 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of FOLH1 mRNA Vitamin E results in decreased expression of FOLH1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:140,428,101...140,501,563
Ensembl chr 1:140,428,101...140,501,379
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Vitamin E promotes the reaction [Alcohols results in increased expression of FOS mRNA] |
CTD |
PMID:18814483 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxa2 |
forkhead box A2 |
multiple interactions |
EXP ISO |
Vitamin E inhibits the reaction [nitrofen results in decreased expression of FOXA2 protein] Vitamin E inhibits the reaction [nitrofen results in decreased expression of FOXA2 mRNA] |
CTD |
PMID:16490937 PMID:16863852 |
|
NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
|
|
G |
Foxe1 |
forkhead box E1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FOXE1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:60,630,027...60,632,835
Ensembl chr 5:60,630,027...60,632,835
|
|
G |
Foxf2 |
forkhead box F2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FOXF2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:32,835,730...32,842,547
Ensembl chr17:32,836,777...32,842,176
|
|
G |
Foxm1 |
forkhead box M1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FOXM1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
|
|
G |
Foxo1 |
forkhead box O1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FOXO1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Frat1 |
FRAT regulator of WNT signaling pathway 1 |
increases expression |
ISO |
Vitamin E results in increased expression of FRAT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:240,638,309...240,640,857
Ensembl chr 1:240,638,296...240,640,945
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of FSHB protein]; Vitamin E inhibits the reaction [chromium hexavalent ion results in increased expression of FSHB protein]; Vitamin E inhibits the reaction [cypermethrin results in decreased expression of FSHB protein]; Vitamin E inhibits the reaction [Petroleum results in increased expression of FSHB protein]; Vitamin E inhibits the reaction [Potassium Dichromate results in increased expression of FSHB protein] |
CTD |
PMID:17280759 PMID:20079796 PMID:24759048 PMID:25046308 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Fst |
follistatin |
increases expression |
ISO |
Vitamin E results in increased expression of FST mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:46,123,260...46,130,584
Ensembl chr 2:46,123,439...46,130,571
|
|
G |
Ftsj1 |
FtsJ RNA 2'-O-methyltransferase 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FTSJ1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:14,243,684...14,256,555
Ensembl chr X:14,244,050...14,252,030
|
|
G |
Fus |
Fus RNA binding protein |
increases expression |
ISO |
Vitamin E results in increased expression of FUS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:182,576,479...182,590,417
Ensembl chr 1:182,576,545...182,590,414
|
|
G |
Fxr1 |
FMR1 autosomal homolog 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of FXR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:116,884,167...116,937,590
Ensembl chr 2:116,884,248...116,937,590
|
|
G |
Fxr2 |
FMR1 autosomal homolog 2 |
increases expression |
ISO |
Vitamin E results in increased expression of FXR2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:54,350,577...54,370,964
Ensembl chr10:54,350,131...54,370,964
|
|
G |
Fxyd6 |
FXYD domain-containing ion transport regulator 6 |
increases expression |
ISO |
Vitamin E results in increased expression of FXYD6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:45,679,054...45,705,958
Ensembl chr 8:45,678,885...45,705,958
|
|
G |
Fzr1 |
fizzy and cell division cycle 20 related 1 |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of FZR1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of FZR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:8,332,029...8,343,953
Ensembl chr 7:8,332,029...8,343,952
|
|
G |
G0s2 |
G0/G1switch 2 |
increases expression |
ISO |
Vitamin E results in increased expression of G0S2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
multiple interactions |
ISO EXP |
Vitamin E inhibits the reaction [sodium arsenite results in decreased activity of G6PD protein] Vitamin E inhibits the reaction [Atrazine results in decreased activity of G6PD protein] |
CTD |
PMID:19635623 PMID:20136348 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gab2 |
GRB2-associated binding protein 2 |
increases expression |
ISO |
Vitamin E results in increased expression of GAB2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:151,429,844...151,625,708
Ensembl chr 1:151,429,695...151,625,031
|
|
G |
Gabpb2 |
GA binding protein transcription factor subunit beta 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GABPB2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:182,755,304...182,795,368
Ensembl chr 2:182,761,359...182,795,109
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of GADD45A mRNA Vitamin E results in decreased expression of GADD45A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gak |
cyclin G associated kinase |
decreases expression |
ISO |
Vitamin E results in decreased expression of GAK mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:1,089,853...1,164,098
Ensembl chr14:1,089,866...1,216,398
|
|
G |
Galnt1 |
polypeptide N-acetylgalactosaminyltransferase 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of GALNT1 mRNA Vitamin E results in decreased expression of GALNT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:15,489,015...15,568,849
Ensembl chr18:15,489,020...15,568,245
|
|
G |
Galnt10 |
polypeptide N-acetylgalactosaminyltransferase 10 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GALNT10 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:41,821,216...41,967,618
Ensembl chr10:41,820,158...41,967,013
|
|
G |
Galnt3 |
polypeptide N-acetylgalactosaminyltransferase 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GALNT3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:50,742,500...50,779,266
Ensembl chr 3:50,742,512...50,766,268
|
|
G |
Galr3 |
galanin receptor 3 |
increases expression |
ISO |
Vitamin E results in increased expression of GALR3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:110,603,525...110,608,429
Ensembl chr 7:110,605,226...110,607,685
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
increases expression |
ISO |
Vitamin E results in increased expression of GAPDH mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Gas8 |
growth arrest specific 8 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of GAS8 mRNA Vitamin E results in increased expression of GAS8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:51,552,770...51,572,323
Ensembl chr19:51,552,816...51,572,305
|
|
G |
Gata4 |
GATA binding protein 4 |
affects expression |
EXP |
Vitamin E affects the expression of GATA4 mRNA |
CTD |
PMID:15370891 |
|
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636
|
|
G |
Gatad1 |
GATA zinc finger domain containing 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GATAD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:30,507,530...30,519,107
Ensembl chr 4:30,507,538...30,519,107
|
|
G |
Gatd3a |
glutamine amidotransferase class 1 domain containing 3A |
increases expression |
ISO |
Vitamin E results in increased expression of GATD3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:10,514,793...10,522,894
Ensembl chr20:10,514,744...10,522,885
|
|
G |
Gbp1 |
guanylate binding protein 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GBP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
|
|
G |
Gcfc2 |
GC-rich sequence DNA-binding factor 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GCFC2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:114,481,613...114,519,268
Ensembl chr 4:114,481,607...114,519,962
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions affects expression |
ISO EXP |
Vitamin E inhibits the reaction [Alcohols results in increased expression of GCLC mRNA] [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of GCLC mRNA; Vitamin E affects the reaction [[REL binds to GCLC promoter] which affects the expression of GCLC mRNA] Vitamin E affects the expression of GCLC mRNA; Vitamin E affects the expression of GCLC protein |
CTD |
PMID:11444866 PMID:16298738 PMID:18814483 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
multiple interactions affects expression |
EXP |
Vitamin E affects the reaction [[REL binds to GCLM promoter] which affects the expression of GCLM mRNA] Vitamin E affects the expression of GCLM mRNA |
CTD |
PMID:16298738 PMID:20447326 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gdap1l1 |
ganglioside-induced differentiation-associated protein 1-like 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GDAP1L1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:152,110,225...152,129,693
Ensembl chr 3:152,110,253...152,128,711
|
|
G |
Gdi1 |
GDP dissociation inhibitor 1 |
increases expression |
ISO |
Vitamin E results in increased expression of GDI1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:152,087,611...152,094,274
Ensembl chr X:152,087,444...152,094,272
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Aluminum results in increased expression of GFAP protein] |
CTD |
PMID:16545059 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gfod1 |
Gfo/Idh/MocA-like oxidoreductase domain containing 1 |
increases expression |
ISO |
Vitamin E results in increased expression of GFOD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:21,400,142...21,504,972
Ensembl chr17:21,399,479...21,499,938
|
|
G |
Gfus |
GDP-L-fucose synthase |
increases expression |
ISO |
Vitamin E results in increased expression of GFUS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:107,612,087...107,617,005
Ensembl chr 7:107,612,094...107,616,948
|
|
G |
Ggps1 |
geranylgeranyl diphosphate synthase 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GGPS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:51,263,262...51,282,471
Ensembl chr17:51,263,263...51,276,220
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
multiple interactions |
ISO EXP |
[Selenium co-treated with Vitamin E] results in increased expression of GGT1 mRNA Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of GGT1 protein] |
CTD |
PMID:16298753 PMID:19244175 |
|
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Gigyf2 |
GRB10 interacting GYF protein 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GIGYF2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:88,001,212...88,127,040
Ensembl chr 9:88,001,301...88,125,715
|
|
G |
Gimap5 |
GTPase, IMAP family member 5 |
increases expression |
ISO |
Vitamin E results in increased expression of GIMAP5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:77,693,417...77,701,025
Ensembl chr 4:77,687,564...77,703,086
|
|
G |
Gipc1 |
GIPC PDZ domain containing family, member 1 |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of GIPC1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of GIPC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:24,474,291...24,487,083
Ensembl chr19:24,453,123...24,486,997
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
multiple interactions |
EXP |
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of GJA1 protein]; [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of GJA1 protein] |
CTD |
PMID:29940330 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Glg1 |
golgi glycoprotein 1 |
decreases expression increases expression |
ISO |
Vitamin E results in decreased expression of GLG1 mRNA Vitamin E results in increased expression of GLG1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:39,124,892...39,224,178
Ensembl chr19:39,124,641...39,224,178
|
|
G |
Gli2 |
GLI family zinc finger 2 |
increases expression |
ISO |
Vitamin E results in increased expression of GLI2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:29,946,882...30,163,589
Ensembl chr13:29,946,809...30,163,574
|
|
G |
Glmn |
glomulin, FKBP associated protein |
decreases expression |
ISO |
Vitamin E results in decreased expression of GLMN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:2,187,144...2,231,295
Ensembl chr14:2,187,642...2,230,420
|
|
G |
Gmppa |
GDP-mannose pyrophosphorylase A |
increases expression |
ISO |
Vitamin E results in increased expression of GMPPA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:76,926,724...76,934,274
Ensembl chr 9:76,926,739...76,934,269
|
|
G |
Gnas |
GNAS complex locus |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of GNAS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
|
|
G |
Gnaz |
G protein subunit alpha z |
increases expression |
ISO |
Vitamin E results in increased expression of GNAZ mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:13,643,473...13,694,240
Ensembl chr20:13,644,640...13,669,907
|
|
G |
Gng4 |
G protein subunit gamma 4 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GNG4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:86,448,708...86,497,560
Ensembl chr17:86,449,022...86,495,254
|
|
G |
Golga3 |
golgin A3 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of GOLGA3 mRNA Vitamin E results in increased expression of GOLGA3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:46,452,409...46,500,509
Ensembl chr12:46,454,870...46,500,509 Ensembl chr 4:46,454,870...46,500,509
|
|
G |
Gosr1 |
golgi SNAP receptor complex member 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GOSR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:61,570,499...61,607,287
Ensembl chr10:61,450,494...61,607,177 Ensembl chr10:61,450,494...61,607,177
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Hexachlorobenzene results in increased activity of GOT1 protein]; Vitamin E inhibits the reaction [Tramadol results in increased expression of GOT1 protein] |
CTD |
PMID:30064338 PMID:31618080 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gp6 |
glycoprotein VI |
decreases expression |
ISO |
Vitamin E results in decreased expression of GP6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:69,429,232...69,492,709
Ensembl chr 1:69,465,789...69,491,326
|
|
G |
Gpatch8 |
G patch domain containing 8 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GPATCH8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:87,432,020...87,512,594
Ensembl chr10:87,433,266...87,512,419
|
|
G |
Gpi |
glucose-6-phosphate isomerase |
increases expression |
ISO |
Vitamin E results in increased expression of GPI mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086
|
|
G |
Gpkow |
G patch domain and KOW motifs |
increases expression |
ISO |
Vitamin E results in increased expression of GPKOW mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:14,791,601...14,806,384
Ensembl chr X:14,791,610...14,806,384
|
|
G |
Gpn3 |
GPN-loop GTPase 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GPN3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:34,189,285...34,198,251
Ensembl chr12:34,189,577...34,198,206
|
|
G |
Gpr107 |
G protein-coupled receptor 107 |
increases expression |
ISO |
Vitamin E results in increased expression of GPR107 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:14,431,704...14,497,623
Ensembl chr 3:14,434,723...14,495,958
|
|
G |
Gprin2 |
G protein regulated inducer of neurite outgrowth 2 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of GPRIN2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of GPRIN2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:9,496,452...9,512,672
Ensembl chr16:9,505,643...9,507,010
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
[Quercetin co-treated with Vitamin E] inhibits the reaction [Cyclosporine results in increased activity of GPT protein]; Vitamin E inhibits the reaction [Cyclophosphamide results in increased expression of GPT protein]; Vitamin E inhibits the reaction [Cyclosporine results in increased activity of GPT protein]; Vitamin E inhibits the reaction [Food Additives results in increased activity of GPT protein]; Vitamin E inhibits the reaction [Hexachlorobenzene results in increased activity of GPT protein]; Vitamin E inhibits the reaction [Tramadol results in increased expression of GPT protein] |
CTD |
PMID:16758767 PMID:17927767 PMID:25779342 PMID:30064338 PMID:31618080 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions decreases expression |
ISO EXP |
[Ascorbic Acid co-treated with Vitamin E] results in increased expression of GPX1 mRNA; [Vitamin A co-treated with Ascorbic Acid co-treated with Vitamin E] results in increased expression of GPX1 protein; Vitamin E inhibits the reaction [Aluminum results in decreased activity of GPX1 protein] Vitamin E decreases expression of Gpx1 mRNA in distal colon [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of GPX1 protein]; [Curcumin co-treated with Vitamin E] inhibits the reaction [Thyroxine results in increased expression of GPX1 protein]; [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of GPX1 mRNA; [Vitamin E co-treated with Folic Acid] inhibits the reaction [Hydrogen Peroxide results in decreased activity of GPX1 protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of GPX1 protein]; Vitamin E inhibits the reaction [Endosulfan results in increased activity of GPX1 protein]; Vitamin E inhibits the reaction [Hexachlorobenzene results in increased activity of GPX1 protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased expression of GPX1 mRNA] |
CTD RGD |
PMID:11444866 PMID:15337585 PMID:16298753 PMID:17179735 PMID:17709913 PMID:19914224 PMID:22207723 PMID:28849685 PMID:29663635 PMID:30064338 PMID:16038882 More...
|
RGD:152998891 |
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [phoxim results in increased expression of GPX2 mRNA] |
CTD |
PMID:30003487 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
increases expression |
ISO |
Vitamin E results in increased expression of GPX3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Grhpr |
glyoxylate and hydroxypyruvate reductase |
increases expression |
ISO |
Vitamin E results in increased expression of GRHPR mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:59,234,179...59,243,614
Ensembl chr 5:59,234,192...59,243,603
|
|
G |
Gria2 |
glutamate ionotropic receptor AMPA type subunit 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GRIA2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
|
|
G |
Grina |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of GRINA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:107,962,194...107,965,372
Ensembl chr 7:107,962,207...107,965,366
|
|
G |
Grk3 |
G protein-coupled receptor kinase 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GRK3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:43,624,778...43,735,375
Ensembl chr12:43,624,897...43,731,262
|
|
G |
Grn |
granulin precursor |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of GRN mRNA Vitamin E results in increased expression of GRN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
|
|
G |
Gsk3a |
glycogen synthase kinase 3 alpha |
increases expression |
ISO |
Vitamin E results in increased expression of GSK3A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:80,815,843...80,825,732
Ensembl chr 1:80,815,850...80,825,802
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of GSK3B mRNA Vitamin E results in decreased expression of GSK3B mRNA Vitamin E inhibits the reaction [wortmannin results in decreased expression of GSK3B protein modified form] |
CTD |
PMID:15842767 PMID:19244175 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsn |
gelsolin |
increases expression |
ISO |
Vitamin E results in increased expression of GSN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO EXP |
Vitamin E inhibits the reaction [Cadmium results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Ethanol results in decreased activity of GSR protein] [Curcumin co-treated with Vitamin E] inhibits the reaction [Thyroxine results in decreased expression of GSR mRNA]; [Vitamin E co-treated with coenzyme Q10] inhibits the reaction [Cadmium Chloride results in decreased activity of GSR protein]; [Vitamin E co-treated with coenzyme Q10] results in increased activity of GSR protein; [Vitamin E co-treated with Folic Acid] inhibits the reaction [Hydrogen Peroxide results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Cadmium Chloride results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Cadmium results in increased activity of GSR protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Diethylnitrosamine results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Hydrogen Peroxide results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Methoxychlor results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Tetrachlorodibenzodioxin results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased expression of GSR mRNA] |
CTD |
PMID:11955947 PMID:12355564 PMID:14535831 PMID:16144695 PMID:16298753 PMID:17262218 PMID:19914224 PMID:19958828 PMID:21086752 PMID:28849685 More...
|
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gstk1 |
glutathione S-transferase kappa 1 |
increases expression |
ISO |
Vitamin E results in increased expression of GSTK1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:71,118,896...71,123,292
|
|
G |
Gstm5l |
glutathione S-transferase, mu 5-like |
increases expression |
ISO |
Vitamin E results in increased expression of GSTM5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:195,544,424...195,549,895
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of GSTP1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of GSTP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gtf2f1 |
general transcription factor IIF subunit 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GTF2F1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:1,844,027...1,853,455
Ensembl chr 9:1,843,901...1,853,423
|
|
G |
Gtf2ird1 |
GTF2I repeat domain containing 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of GTF2IRD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:22,254,113...22,361,052
Ensembl chr12:22,254,221...22,361,040
|
|
G |
Gtpbp8 |
GTP binding protein 8 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of GTPBP8 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of GTPBP8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:55,945,778...55,955,743
Ensembl chr11:55,945,795...55,955,635
|
|
G |
H3f3a |
H3.3 histone A |
decreases expression |
ISO |
Vitamin E results in decreased expression of H3-3A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:92,533,289...92,544,902
Ensembl chr13:92,533,298...92,544,908
|
|
G |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of H6PD mRNA [Selenium co-treated with Vitamin E] results in decreased expression of H6PD mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:160,434,499...160,470,203
Ensembl chr 5:160,438,697...160,470,171
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
decreases expression |
ISO |
Vitamin E results in decreased expression of HADHA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
|
|
G |
Hagh |
hydroxyacyl glutathione hydrolase |
increases expression |
ISO |
Vitamin E results in increased expression of HAGH mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:13,874,883...13,889,527
Ensembl chr10:13,875,241...13,889,504
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [Ethanol results in decreased expression of HAMP mRNA] |
CTD |
PMID:16737972 |
|
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
|
|
G |
Hars1 |
histidyl-tRNA synthetase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of HARS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:28,381,649...28,398,699
Ensembl chr18:28,381,655...28,398,740
|
|
G |
Haus3 |
HAUS augmin-like complex, subunit 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of HAUS3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:76,580,549...76,599,542
Ensembl chr14:76,580,546...76,752,463
|
|
G |
Haus4 |
HAUS augmin-like complex, subunit 4 |
increases expression |
ISO |
Vitamin E results in increased expression of HAUS4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:27,994,530...28,006,147
Ensembl chr15:27,994,532...28,005,938
|
|
G |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of HBA1 protein |
CTD |
PMID:1991440 |
|
NCBI chr10:15,323,830...15,324,677
Ensembl chr10:15,307,815...15,338,392 Ensembl chr10:15,307,815...15,338,392
|
|
G |
Hba-a3 |
hemoglobin alpha, adult chain 3 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of HBA2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:15,311,637...15,312,481
Ensembl chr10:15,311,634...15,312,481
|
|
G |
Hcfc1 |
host cell factor C1 |
increases expression |
ISO |
Vitamin E results in increased expression of HCFC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:151,687,779...151,712,688
Ensembl chr X:151,687,779...151,712,638
|
|
G |
Hdac1 |
histone deacetylase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of HDAC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
|
|
G |
Hdac5 |
histone deacetylase 5 |
increases expression |
ISO |
Vitamin E results in increased expression of HDAC5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:87,152,978...87,187,921
Ensembl chr10:87,152,978...87,188,235
|
|
G |
Hemk1 |
HemK methyltransferase family member 1 |
increases expression |
ISO |
Vitamin E results in increased expression of HEMK1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:107,999,658...108,010,732
Ensembl chr 8:107,999,644...108,010,256
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
decreases expression multiple interactions |
ISO EXP |
Vitamin E results in decreased expression of HES1 mRNA [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of HES1 protein] [Selenium co-treated with Vitamin E] results in increased expression of HES1 mRNA |
CTD |
PMID:19244175 PMID:29663635 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
decreases expression |
ISO |
Vitamin E results in decreased expression of HIF1A protein |
CTD |
PMID:16507596 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hif1an |
hypoxia inducible factor 1 subunit alpha inhibitor |
increases expression |
ISO |
Vitamin E results in increased expression of HIF1AN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:243,419,175...243,440,464
Ensembl chr 1:243,419,194...243,434,327
|
|
G |
Higd2a |
HIG1 hypoxia inducible domain family, member 2A |
increases expression |
ISO |
Vitamin E results in increased expression of HIGD2A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:10,021,853...10,022,777
Ensembl chr17:10,021,859...10,022,796
|
|
G |
Hipk2 |
homeodomain interacting protein kinase 2 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of HIPK2 mRNA Vitamin E results in decreased expression of HIPK2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:67,439,327...67,619,223
Ensembl chr 4:67,440,501...67,619,223
|
|
G |
Hmces |
5-hydroxymethylcytosine binding, ES cell specific |
increases expression |
ISO |
Vitamin E results in increased expression of HMCES mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:120,392,812...120,415,616
Ensembl chr 4:120,366,542...120,415,616
|
|
G |
Hmgb1 |
high mobility group box 1 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of HMGB1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HMGB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Hmgxb4 |
HMG-box containing 4 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of HMGXB4 mRNA Vitamin E results in decreased expression of HMGXB4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:13,364,741...13,403,563
Ensembl chr19:13,364,807...13,403,563
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
EXP ISO |
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of HMOX1 protein] [Vitamin E co-treated with bioallethrin] results in increased expression of HMOX1 protein; Vitamin E inhibits the reaction [Polychlorinated Biphenyls analog results in increased expression of HMOX1 protein] Vitamin E results in increased expression of HMOX1 mRNA |
CTD |
PMID:15571180 PMID:24361488 PMID:29663635 PMID:29940330 PMID:30513525 PMID:35511042 More...
|
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnmt |
histamine N-methyltransferase |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of HNMT mRNA Vitamin E results in decreased expression of HNMT mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:6,591,804...6,623,821
Ensembl chr 3:6,591,463...6,624,012
|
|
G |
Hnrnpm |
heterogeneous nuclear ribonucleoprotein M |
increases expression |
ISO |
Vitamin E results in increased expression of HNRNPM mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:14,438,703...14,476,781
Ensembl chr 7:14,438,688...14,476,762
|
|
G |
Hnrnpr |
heterogeneous nuclear ribonucleoprotein R |
decreases expression |
ISO |
Vitamin E results in decreased expression of HNRNPR mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:148,542,999...148,574,888
Ensembl chr 5:148,543,044...148,574,867
|
|
G |
Homer1 |
homer scaffold protein 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of HOMER1 mRNA Vitamin E results in decreased expression of HOMER1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:24,542,777...24,645,715
Ensembl chr 2:24,543,093...24,644,785
|
|
G |
Hook1 |
hook microtubule-tethering protein 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of HOOK1 mRNA Vitamin E results in decreased expression of HOOK1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:110,824,501...110,887,791
Ensembl chr 5:110,824,501...110,887,787
|
|
G |
Hoxa11 |
homeobox A11 |
increases expression |
ISO |
Vitamin E results in increased expression of HOXA11 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:81,342,527...81,346,189
Ensembl chr 4:81,342,528...81,346,232
|
|
G |
Hoxa7 |
homeobox A7 |
decreases expression |
ISO |
Vitamin E results in decreased expression of HOXA7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:81,315,730...81,317,629
Ensembl chr 4:81,314,625...81,317,659
|
|
G |
Hpcal1 |
hippocalcin-like 1 |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of HPCAL1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HPCAL1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:40,478,206...40,584,721
Ensembl chr 6:40,478,208...40,584,687
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased mutagenesis of HPRT1 gene] |
CTD |
PMID:12467141 |
|
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
multiple interactions increases expression |
ISO |
Vitamin E inhibits the reaction [Urethane promotes the reaction [RAF1 protein binds to HRAS protein]] Vitamin E results in increased expression of HRAS mRNA [Selenium co-treated with Vitamin E] results in increased expression of HRAS mRNA |
CTD |
PMID:11062179 PMID:19244175 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of HSD11B1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
multiple interactions |
EXP |
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of HSD11B2 mRNA |
CTD |
PMID:11444866 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of HSD17B3 mRNA] |
CTD |
PMID:17280759 |
|
NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554
|
|
G |
Hsd17b8 |
hydroxysteroid (17-beta) dehydrogenase 8 |
increases expression |
ISO |
Vitamin E results in increased expression of HSD17B8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:4,826,725...4,828,742
Ensembl chr20:4,822,026...4,828,742
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of HSD3B1 mRNA] |
CTD |
PMID:17280759 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of HSP90AA1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HSP90AA1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha family class B member 1 |
increases expression |
ISO |
Vitamin E results in increased expression of HSP90AB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
|
|
G |
Hsp90b1 |
heat shock protein 90 beta family member 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of HSP90B1 mRNA Vitamin E results in decreased expression of HSP90B1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
increases expression |
ISO |
Vitamin E results in increased expression of HSPA1A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa4 |
heat shock protein family A (Hsp70) member 4 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of HSPA4 mRNA Vitamin E results in increased expression of HSPA4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:37,408,025...37,449,080
Ensembl chr10:37,408,025...37,449,001
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [pyrazole results in increased expression of HSPA5 protein] |
CTD |
PMID:18068688 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa9 |
heat shock protein family A (Hsp70) member 9 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of HSPA9 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HSPA9 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
increases expression |
ISO |
Vitamin E results in increased expression of HSPB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Htra1 |
HtrA serine peptidase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of HTRA1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
|
|
G |
Htra2 |
HtrA serine peptidase 2 |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [cinnamaldehyde affects the localization of HTRA2 protein] |
CTD |
PMID:15566391 |
|
NCBI chr 4:115,556,914...115,560,202
Ensembl chr 4:115,556,916...115,560,095
|
|
G |
Iars1 |
isoleucyl-tRNA synthetase 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of IARS1 mRNA Vitamin E results in decreased expression of IARS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:14,940,919...14,987,277
Ensembl chr17:14,940,924...14,987,237
|
|
G |
Ica1 |
islet cell autoantigen 1 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ICA1 mRNA Vitamin E results in increased expression of ICA1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:36,656,475...36,804,705
Ensembl chr 4:36,656,475...36,804,298
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
[Vitamin E co-treated with Bezafibrate] results in decreased expression of ICAM1 protein modified form; Vitamin E inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of ICAM1 protein]; Vitamin E inhibits the reaction [Norepinephrine results in increased expression of ICAM1 mRNA]; Vitamin E inhibits the reaction [Simvastatin results in decreased expression of ICAM1 protein modified form] |
CTD |
PMID:14602771 PMID:23114885 PMID:35349355 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ID2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
|
|
G |
Idh3b |
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta |
increases expression |
ISO |
Vitamin E results in increased expression of IDH3B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:117,481,845...117,486,909
Ensembl chr 3:117,481,845...117,486,982
|
|
G |
Idh3g |
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of IDH3G mRNA Vitamin E results in increased expression of IDH3G mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:151,515,244...151,524,175
Ensembl chr X:151,515,247...151,524,171
|
|
G |
Ids |
iduronate 2-sulfatase |
increases expression |
ISO |
Vitamin E results in increased expression of IDS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:149,025,976...149,046,641
Ensembl chr X:149,025,976...149,046,663
|
|
G |
Idua |
alpha-L-iduronidase |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of IDUA mRNA [Selenium co-treated with Vitamin E] results in increased expression of IDUA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:1,031,588...1,059,494
Ensembl chr14:1,032,171...1,046,522
|
|
G |
Iffo1 |
intermediate filament family orphan 1 |
increases expression |
ISO |
Vitamin E results in increased expression of IFFO1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:157,945,075...157,962,302
Ensembl chr 4:157,945,107...157,962,302
|
|
G |
Ifi35 |
interferon-induced protein 35 |
increases expression |
ISO |
Vitamin E results in increased expression of IFI35 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:86,381,023...86,389,279
Ensembl chr10:86,381,010...86,389,952
|
|
G |
Ifitm1 |
interferon induced transmembrane protein 1 |
increases expression |
ISO |
Vitamin E results in increased expression of IFITM1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
|
|
G |
Ifitm2 |
interferon induced transmembrane protein 2 |
increases expression |
ISO |
Vitamin E results in increased expression of IFITM2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:196,051,539...196,052,719
Ensembl chr 1:196,051,537...196,052,741
|
|
G |
Ifitm3 |
interferon induced transmembrane protein 3 |
increases expression |
ISO |
Vitamin E results in increased expression of IFITM3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
|
|
G |
Ifng |
interferon gamma |
multiple interactions decreases expression |
ISO EXP |
Vitamin E inhibits the reaction [Ethanol results in increased activity of IFNG protein] Vitamin E inhibits the reaction [APP protein modified form promotes the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 protein]] Vitamin E results in decreased expression of IFNG protein |
CTD |
PMID:14624943 PMID:15223066 PMID:21086752 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ift74 |
intraflagellar transport 74 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of IFT74 mRNA Vitamin E results in decreased expression of IFT74 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:109,460,372...109,563,839
Ensembl chr 5:109,474,255...109,563,833
|
|
G |
Ift81 |
intraflagellar transport 81 |
decreases expression |
ISO |
Vitamin E results in decreased expression of IFT81 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:33,957,744...34,037,164
Ensembl chr12:33,957,806...34,037,057
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
multiple interactions decreases expression |
ISO EXP |
Rutin results in increased susceptibility to [Vitamin E results in decreased expression of IGF1R protein] Vitamin E inhibits the reaction [Thyroxine results in increased expression of IGF1R protein] Vitamin E results in decreased expression of IGF1R mRNA; Vitamin E results in decreased expression of IGF1R protein |
CTD |
PMID:17447016 PMID:19244175 PMID:20015448 |
|
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igf2bp2 |
insulin-like growth factor 2 mRNA binding protein 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of IGF2BP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:78,874,402...78,974,392
Ensembl chr11:78,874,414...78,974,377
|
|
G |
Igf2r |
insulin-like growth factor 2 receptor |
decreases expression |
ISO |
Vitamin E results in decreased expression of IGF2R mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
increases expression |
ISO |
Vitamin E results in increased expression of IGFBP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
|
|
G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
increases expression |
ISO |
Vitamin E results in increased expression of IGFBP4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225
|
|
G |
Igfbp6 |
insulin-like growth factor binding protein 6 |
increases expression |
ISO |
Vitamin E results in increased expression of IGFBP6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:133,276,309...133,280,944
Ensembl chr 7:133,276,234...133,280,966
|
|
G |
Ik |
IK cytokine |
increases expression |
ISO |
Vitamin E results in increased expression of IK mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:28,358,004...28,372,809
Ensembl chr18:28,357,977...28,378,832
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO EXP |
Vitamin E inhibits the reaction [Ethanol results in increased activity of IL10 protein] [Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] inhibits the reaction [Streptozocin results in decreased expression of IL10 protein] |
CTD |
PMID:15862027 PMID:21086752 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il13 |
interleukin 13 |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [Ozone results in increased expression of IL13 protein] |
CTD |
PMID:30090343 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il13ra1 |
interleukin 13 receptor subunit alpha 1 |
increases expression |
ISO |
Vitamin E results in increased expression of IL13RA1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:115,348,822...115,408,682
Ensembl chr X:115,348,860...115,408,681 Ensembl chr11:115,348,860...115,408,681
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
ISO EXP |
alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of IL1B mRNA]; Quercetin inhibits the reaction [Vitamin E deficiency results in increased expression of IL1B mRNA] Vitamin E inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of IL1B protein] Vitamin E inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased chemical synthesis of Nitric Oxide]; Vitamin E inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 protein]; Vitamin E inhibits the reaction [Aluminum results in increased expression of IL1B protein]; Vitamin E inhibits the reaction [Vehicle Emissions results in increased expression of IL1B mRNA] |
CTD |
PMID:15223066 PMID:16545059 PMID:18234736 PMID:19735175 PMID:35349355 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Formaldehyde results in increased expression of IL2 protein] |
CTD |
PMID:16937016 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il4 |
interleukin 4 |
decreases expression multiple interactions |
ISO EXP |
Vitamin E results in decreased expression of IL4 protein Vitamin E inhibits the reaction [Ozone results in increased expression of IL4 protein] [Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] results in increased expression of IL4 protein |
CTD |
PMID:14624943 PMID:15862027 PMID:30090343 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il4r |
interleukin 4 receptor |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of IL4R mRNA [Selenium co-treated with Vitamin E] results in decreased expression of IL4R mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
|
|
G |
Il5 |
interleukin 5 |
multiple interactions |
ISO |
[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of IL5 mRNA Vitamin E inhibits the reaction [Ozone results in increased expression of IL5 protein] |
CTD |
PMID:16797527 PMID:30090343 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Il6 |
interleukin 6 |
multiple interactions decreases expression |
ISO EXP |
[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of IL6 mRNA; Vitamin E inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of IL6 protein] Vitamin E inhibits the reaction [phoxim results in decreased expression of IL6 mRNA]; Vitamin E inhibits the reaction [Vehicle Emissions results in increased expression of IL6 mRNA]; Vitamin E inhibits the reaction [Vehicle Emissions results in increased expression of IL6 protein] Vitamin E results in decreased expression of IL6 protein |
CTD |
PMID:16797527 PMID:18234736 PMID:20370442 PMID:30003487 PMID:35349355 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ilf3 |
interleukin enhancer binding factor 3 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ILF3 mRNA Vitamin E results in decreased expression of ILF3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:19,922,409...19,960,495
Ensembl chr 8:19,922,460...19,960,350
|
|
G |
Ilk |
integrin-linked kinase |
increases expression |
ISO |
Vitamin E results in increased expression of ILK mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:160,088,839...160,095,140
Ensembl chr 1:160,088,897...160,095,140
|
|
G |
Inpp5k |
inositol polyphosphate-5-phosphatase K |
increases expression |
ISO |
Vitamin E results in increased expression of INPP5K mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:60,474,262...60,495,813
Ensembl chr10:60,475,897...60,496,773
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
ISO EXP |
[Selenium co-treated with Vitamin E co-treated with Vanadium co-treated with Chromium] results in increased expression of INS1 mRNA; [Selenium co-treated with Vitamin E co-treated with Vanadium co-treated with Chromium] results in increased expression of INS1 protein [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of INS1 protein]; Vitamin E inhibits the reaction [Triiodothyronine, Reverse inhibits the reaction [INS1 protein results in increased uptake of Glucose]] |
CTD |
PMID:17198541 PMID:20108212 PMID:21911000 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Insr |
insulin receptor |
multiple interactions |
EXP |
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of INSR mRNA] |
CTD |
PMID:21911000 |
|
NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
|
|
G |
Ints15 |
integrator complex subunit 15 |
increases expression |
ISO |
Vitamin E results in increased expression of INTS15 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:11,245,045...11,260,170
Ensembl chr12:11,245,842...11,260,166
|
|
G |
Ints6 |
integrator complex subunit 6 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of INTS6 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of INTS6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:36,908,966...37,048,043
Ensembl chr15:36,933,724...37,021,527
|
|
G |
Ipp |
intracisternal A particle-promoted polypeptide |
decreases expression |
ISO |
Vitamin E results in decreased expression of IPP mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:129,962,528...130,001,237
Ensembl chr 5:129,962,643...130,001,242
|
|
G |
Iqcb1 |
IQ motif containing B1 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of IQCB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:63,905,595...63,960,141
Ensembl chr11:63,905,590...63,960,093
|
|
G |
Iqck |
IQ motif containing K |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of IQCK mRNA [Selenium co-treated with Vitamin E] results in decreased expression of IQCK mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:173,199,308...173,316,982
Ensembl chr 1:173,199,316...173,316,984
|
|
G |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of IQGAP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:134,679,581...134,769,776
Ensembl chr 1:134,679,586...134,769,755
|
|
G |
Iqsec1 |
IQ motif and Sec7 domain ArfGEF 1 |
increases expression |
ISO |
Vitamin E results in increased expression of IQSEC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:123,168,719...123,488,300
Ensembl chr 4:123,168,719...123,488,172
|
|
G |
Irf9 |
interferon regulatory factor 9 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of IRF9 mRNA Vitamin E results in increased expression of IRF9 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:29,095,474...29,101,924
Ensembl chr15:29,095,789...29,101,236
|
|
G |
Irs1 |
insulin receptor substrate 1 |
multiple interactions decreases expression |
ISO EXP |
Rutin results in increased susceptibility to [Vitamin E results in decreased expression of IRS1 protein]; Vitamin E results in increased susceptibility to [Rutin results in decreased expression of IRS1 protein] [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of IRS1 protein]; [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased phosphorylation of IRS1 protein] |
CTD |
PMID:20015448 PMID:21911000 |
|
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
|
|
G |
Isca1 |
iron-sulfur cluster assembly 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ISCA1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:4,905,291...4,917,955
Ensembl chr17:4,905,287...4,917,955
|
|
G |
Islr |
immunoglobulin superfamily containing leucine-rich repeat |
increases expression |
ISO |
Vitamin E results in increased expression of ISLR mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:58,571,155...58,574,128
Ensembl chr 8:58,570,777...58,574,130
|
|
G |
Isyna1 |
inositol-3-phosphate synthase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of ISYNA1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:18,839,143...18,841,979
Ensembl chr16:18,839,145...18,841,979
|
|
G |
Itga3 |
integrin subunit alpha 3 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ITGA3 mRNA Vitamin E results in increased expression of ITGA3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118
|
|
G |
Itgb3bp |
integrin subunit beta 3 binding protein |
decreases expression |
ISO |
Vitamin E results in decreased expression of ITGB3BP mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:114,460,217...114,525,538
Ensembl chr 5:114,460,221...114,525,704
|
|
G |
Itm2c |
integral membrane protein 2C |
increases expression |
ISO |
Vitamin E results in increased expression of ITM2C mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:86,545,927...86,559,745
Ensembl chr 9:86,545,921...86,559,742
|
|
G |
Itpkb |
inositol-trisphosphate 3-kinase B |
increases expression |
ISO |
Vitamin E results in increased expression of ITPKB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:92,069,160...92,164,281
Ensembl chr13:92,069,216...92,162,004
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases phosphorylation decreases expression |
ISO |
Rutin results in increased susceptibility to [Vitamin E results in decreased expression of JUN protein]; Vitamin E results in increased susceptibility to [Rutin results in decreased expression of JUN protein] Vitamin E promotes the reaction [Alcohols results in increased expression of JUN mRNA] Vitamin E results in increased phosphorylation of JUN protein Vitamin E results in decreased expression of JUN mRNA; Vitamin E results in decreased expression of JUN protein |
CTD |
PMID:11522656 PMID:18814483 PMID:19244175 PMID:20015448 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kat5 |
lysine acetyltransferase 5 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of KAT5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:202,895,751...202,903,178
Ensembl chr 1:202,895,751...202,903,458
|
|
G |
Kbtbd2 |
kelch repeat and BTB domain containing 2 |
increases expression |
ISO |
Vitamin E results in increased expression of KBTBD2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:86,027,947...86,050,266
Ensembl chr 4:86,027,947...86,050,211
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
multiple interactions increases expression |
ISO |
Vitamin E inhibits the reaction [TNF protein results in decreased activity of KCNH2 protein] Vitamin E results in increased expression of KCNH2 mRNA |
CTD |
PMID:14973143 PMID:19244175 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Kcnj5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
decreases expression |
ISO |
Vitamin E results in decreased expression of KCNJ5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:30,724,923...30,753,083
Ensembl chr 8:30,724,925...30,753,518
|
|
G |
Kcnj8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
increases expression |
ISO |
Vitamin E results in increased expression of KCNJ8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:175,508,908...175,515,829
Ensembl chr 4:175,508,912...175,515,603
|
|
G |
Kctd17 |
potassium channel tetramerization domain containing 17 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of KCTD17 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:109,979,060...110,009,091
Ensembl chr 7:109,979,060...110,008,927
|
|
G |
Kctd2 |
potassium channel tetramerization domain containing 2 |
increases expression |
ISO |
Vitamin E results in increased expression of KCTD2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:100,663,013...100,674,756
Ensembl chr10:100,662,884...100,674,336
|
|
G |
Kdm6b |
lysine demethylase 6B |
increases expression |
ISO |
Vitamin E results in increased expression of KDM6B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:54,120,716...54,142,212
Ensembl chr10:54,121,848...54,130,794
|
|
G |
Khdrbs1 |
KH RNA binding domain containing, signal transduction associated 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of KHDRBS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:142,051,844...142,089,175
Ensembl chr 5:142,063,570...142,089,180
|
|
G |
Kiaa0930 |
KIAA0930 homolog |
increases expression |
ISO |
Vitamin E results in increased expression of KIAA0930 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:116,067,974...116,107,678
Ensembl chr 7:116,071,447...116,107,727
|
|
G |
Kif16b |
kinesin family member 16B |
decreases expression |
ISO |
Vitamin E results in decreased expression of KIF16B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:129,974,692...130,254,194
Ensembl chr 3:129,974,800...130,254,019
|
|
G |
Kif1b |
kinesin family member 1B |
decreases expression |
ISO |
Vitamin E results in decreased expression of KIF1B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:159,607,697...159,742,778
Ensembl chr 5:159,561,271...159,742,778
|
|
G |
Kif5b |
kinesin family member 5B |
decreases expression |
ISO |
Vitamin E results in decreased expression of KIF5B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:51,489,904...51,527,508
Ensembl chr17:51,489,944...51,527,508
|
|
G |
Kif5c |
kinesin family member 5C |
decreases expression |
ISO |
Vitamin E results in decreased expression of KIF5C mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:34,032,082...34,185,597
Ensembl chr 3:34,032,105...34,182,413
|
|
G |
Kl |
Klotho |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of KL mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:490,402...531,417
Ensembl chr12:490,399...530,080
|
|
G |
Klc1 |
kinesin light chain 1 |
increases expression |
ISO |
Vitamin E results in increased expression of KLC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:130,823,416...130,866,729
Ensembl chr 6:130,823,419...130,867,031
|
|
G |
Klf6 |
KLF transcription factor 6 |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [[CYP2E1 protein co-treated with Paraquat] results in increased expression of KLF6 protein]; Vitamin E inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; Vitamin E inhibits the reaction [Arachidonic Acid promotes the reaction [CYP2E1 protein results in increased expression of KLF6 mRNA]]; Vitamin E inhibits the reaction [CYP2E1 protein promotes the reaction [Arachidonic Acid results in increased expression of KLF6 mRNA alternative form]] |
CTD |
PMID:22486562 |
|
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
|
|
G |
Klf9 |
KLF transcription factor 9 |
decreases expression |
ISO |
Vitamin E results in decreased expression of KLF9 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:220,700,108...220,725,110
Ensembl chr 1:220,700,108...220,725,037
|
|
G |
Klhdc10 |
kelch domain containing 10 |
decreases expression |
ISO |
Vitamin E results in decreased expression of KLHDC10 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:59,021,300...59,079,118
Ensembl chr 4:59,021,310...59,074,941
|
|
G |
Klhl20 |
kelch-like family member 20 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of KLHL20 mRNA Vitamin E results in decreased expression of KLHL20 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:73,363,451...73,408,293
Ensembl chr13:73,363,455...73,408,337
|
|
G |
Klhl24 |
kelch-like family member 24 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of KLHL24 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:80,843,621...80,877,649
Ensembl chr11:80,846,755...80,877,636
|
|
G |
Klhl4 |
kelch-like family member 4 |
decreases expression |
ISO |
Vitamin E results in decreased expression of KLHL4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:79,429,193...79,719,482
Ensembl chr X:79,622,113...79,719,480
|
|
G |
Klhl9 |
kelch-like family member 9 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of KLHL9 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:103,333,747...103,337,931
|
|
G |
Kmt2b |
lysine methyltransferase 2B |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of KMT2B mRNA Vitamin E results in increased expression of KMT2B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:85,821,700...85,840,987
Ensembl chr 1:85,821,753...85,841,326
|
|
G |
Kpna1 |
karyopherin subunit alpha 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of KPNA1 mRNA Vitamin E results in decreased expression of KPNA1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:64,715,844...64,774,647
Ensembl chr11:64,717,563...64,774,623
|
|
G |
Kpna3 |
karyopherin subunit alpha 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of KPNA3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:35,536,310...35,610,066
Ensembl chr15:35,536,316...35,610,419
|
|
G |
Kpnb1 |
karyopherin subunit beta 1 |
decreases expression increases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of KPNB1 mRNA Vitamin E results in increased expression of KPNB1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of KPNB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:82,145,662...82,174,437
Ensembl chr10:82,145,420...82,174,605
|
|
G |
Ktn1 |
kinectin 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of KTN1 mRNA Vitamin E results in decreased expression of KTN1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:20,913,665...21,002,588
Ensembl chr15:20,914,642...21,002,578
|
|
G |
Lad1 |
ladinin 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of LAD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:47,249,605...47,263,967
Ensembl chr13:47,249,605...47,263,967
|
|
G |
Lamb2 |
laminin subunit beta 2 |
increases expression |
ISO |
Vitamin E results in increased expression of LAMB2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:109,178,367...109,190,552
Ensembl chr 8:109,178,409...109,190,549
|
|
G |
Lamp1 |
lysosomal-associated membrane protein 1 |
increases expression |
ISO |
Vitamin E results in increased expression of LAMP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:76,355,982...76,380,700
Ensembl chr16:76,355,984...76,381,883
|
|
G |
Lamp2 |
lysosomal-associated membrane protein 2 |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Pilocarpine results in increased expression of LAMP2 protein] |
CTD |
PMID:19272430 |
|
NCBI chr X:117,173,097...117,222,090
Ensembl chr X:117,057,606...117,260,522
|
|
G |
Larp4b |
La ribonucleoprotein 4B |
decreases expression |
ISO |
Vitamin E results in decreased expression of LARP4B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:61,138,663...61,217,423
Ensembl chr17:61,138,709...61,187,960
|
|
G |
Lcmt2 |
leucine carboxyl methyltransferase 2 |
increases expression |
ISO |
Vitamin E results in increased expression of LCMT2 mRNA; Vitamin E results in increased expression of LCMT2 protein |
CTD |
PMID:9359698 |
|
NCBI chr 3:108,099,960...108,102,084
Ensembl chr 3:108,099,961...108,102,084
|
|
G |
Ldb2 |
LIM domain binding 2 |
increases expression |
ISO |
Vitamin E results in increased expression of LDB2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:66,277,044...66,598,071
Ensembl chr14:66,277,085...66,597,778
|
|
G |
Ldha |
lactate dehydrogenase A |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Hexachlorobenzene affects the expression of LDHA protein] |
CTD |
PMID:30064338 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Lep |
leptin |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Dietary Fats results in decreased expression of LEP mRNA]; Vitamin E inhibits the reaction [Dietary Fats results in decreased expression of LEP protein] |
CTD |
PMID:20404018 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lhb |
luteinizing hormone subunit beta |
multiple interactions |
EXP |
[Vitamin E co-treated with LHB protein] results in increased chemical synthesis of Testosterone; Vitamin E inhibits the reaction [acetamiprid results in increased expression of LHB protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of LHB protein]; Vitamin E inhibits the reaction [chromium hexavalent ion results in decreased expression of LHB protein]; Vitamin E inhibits the reaction [cypermethrin results in decreased expression of LHB protein]; Vitamin E inhibits the reaction [Petroleum results in decreased expression of LHB protein]; Vitamin E inhibits the reaction [Potassium Dichromate results in decreased expression of LHB protein] |
CTD |
PMID:16054318 PMID:16298753 PMID:17280759 PMID:20079796 PMID:24759048 PMID:25046308 PMID:28395332 More...
|
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Limch1 |
LIM and calponin homology domains 1 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of LIMCH1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:41,112,579...41,425,001
Ensembl chr14:41,114,803...41,425,191
|
|
G |
Lipt1 |
lipoyltransferase 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of LIPT1 mRNA Vitamin E results in decreased expression of LIPT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:40,107,938...40,118,268
Ensembl chr 9:40,098,615...40,113,565
|
|
G |
Lman2 |
lectin, mannose-binding 2 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of LMAN2 mRNA Vitamin E results in increased expression of LMAN2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:9,269,236...9,286,923
Ensembl chr17:9,269,022...9,287,265
|
|
G |
Lmna |
lamin A/C |
increases expression |
ISO |
Vitamin E results in increased expression of LMNA mRNA |
CTD |
|